3rl1:A (GLU212) to (TRP274) HIV RT DERIVED PEPTIDE COMPLEXED TO HLA-A*0301 | HLA-A*0301, CD8+ T CELL IMMUNITY, HIV DERIVED PEPTIDES, IMMUNE SYSTEM
3rl2:A (GLU212) to (TRP274) HIV NEF DERIVED PEPTIDE NEF73 COMPLEXED TO HLA-A*0301 | HLA-A*0301, CD8+ T CELL IMMUNITY, HIV DERIVED PEPTIDES, IMMUNE SYSTEM
1a1n:A (GLU212) to (TRP274) MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 | MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B3501, HIV, NEF, COMPLEX (ANTIGEN/PEPTIDE)
1a1o:A (GLU212) to (TRP274) MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM | MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B53, MALARIA, COMPLEX (ANTIGEN/PEPTIDE)
4gt7:A (THR369) to (THR434) AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION | IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR
4gt7:A (ASP473) to (VAL543) AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION | IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR
4gt7:B (THR369) to (LYS435) AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION | IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR
4gt7:B (ASP473) to (VAL543) AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION | IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR
4gt7:C (THR369) to (THR434) AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION | IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR
4gt7:C (ASP473) to (VAL543) AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION | IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR
4gt7:D (ASP473) to (VAL543) AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION | IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR
4wdi:A (ASP212) to (TRP274) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4wdi:D (ASP212) to (TRP274) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
1nak:I (PRO151) to (PRO227) IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE)) | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1nam:H (ASP212) to (TRP274) MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX | T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, ALLOREACTIVITY, CROSSREACTIVITY, IMMUNE SYSTEM
1nan:H (ASP212) to (TRP274) MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE | CLASS I MHC, H-2KB, ALLOREACTIVITY, CROSSREACTIVITY, IMMUNE SYSTEM
1nan:L (ASP212) to (TRP274) MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE | CLASS I MHC, H-2KB, ALLOREACTIVITY, CROSSREACTIVITY, IMMUNE SYSTEM
1a4k:H (PRO149) to (LYS209) DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE | IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE
1a4k:B (PRO149) to (PRO213) DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE | IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE
4web:L (ASP149) to (ARG217) STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2 | HEPATITIS C VIRUS, E2, IGG-LIKE FOLD, SCAVENGER RECEPTOR CLASS B TYPE I (SR-BI), CD81, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1nd0:B (GLY169) to (PRO227) CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM
1nd0:D (GLY169) to (PRO227) CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM
1nd0:F (GLY169) to (PRO227) CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM
1nd0:H (GLY169) to (PRO227) CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM
1a6t:B (PRO149) to (PRO212) FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE | IMMUNOGLOBULIN, NEUTRALIZES HUMAN RHINOVIRUS, IGG1
4gw5:B (PRO155) to (PRO219) CQYN MEDITOPE - CETUXIMAB FAB | IGG, IMMUNE SYSTEM, EGFR
1a9e:A (GLU212) to (ARG273) DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS | MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/PEPTIDE)
3ecb:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF MOUSE H-2DD IN COMPLEX WITH PEPTIDE P18-I10 DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120 | CLASS I MAJOR HISTOMPATIBILITY COMPLEX, MHC-I, H-2DD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, COILED COIL, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, LIPOPROTEIN, PALMITATE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
4wi4:A (PRO271) to (LYS338) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
4wi4:B (PRO271) to (LYS338) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
4wi5:A (PRO271) to (LYS338) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
4wi5:B (PRO271) to (LYS338) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
2ojz:H (GLY169) to (PRO227) ANTI-DNA ANTIBODY ED10 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4wj5:A (GLU212) to (TRP274) STRUCTURE OF HLA-A2 IN COMPLEX WITH AN ALTERED PEPTIDE LIGANDS BASED ON MART-1 VARIANT EPITOPE | ANTIGEN PRESENTATION, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA-A2 ANTIGEN, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM
2av1:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN. | TAX PEPTIDE, MHC, MUTATED HLA-A2, E63Q, K66A, IMMUNE SYSTEM
2av1:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN. | TAX PEPTIDE, MHC, MUTATED HLA-A2, E63Q, K66A, IMMUNE SYSTEM
1ae6:H (PRO149) to (VAL211) IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01 | IMMUNOGLOBULIN, FAB FRAGMENT, HUMANISATION
2av7:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN. | TAX PEPTIDE, MHC, MUTATED HLA-A2, K66A., IMMUNE SYSTEM
2av7:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN. | TAX PEPTIDE, MHC, MUTATED HLA-A2, K66A., IMMUNE SYSTEM
1agb:A (GLU212) to (TRP274) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION) | HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
1agd:A (GLU212) to (TRP274) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE) | HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
1age:A (GLU212) to (TRP274) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION) | HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
3rtq:A (PRO217) to (TRP279) STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
2axf:A (GLU212) to (TRP274) THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION | IMMUNE RESPONSE, PMHC, IMMUNE SYSTEM/GENE REGULATION COMPLEX
3rug:A (PRO217) to (TRP279) CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D- ALPHAGLUCOSYLCERAMIDE (C20:2) | MOUSE CD1D, MOUSE NKT, IMMUNE SYSTEM
1akj:A (GLU212) to (ARG273) COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8 | T-CELL, GLYCOPROTEIN, SIGNAL, COMPLEX, IMMUNOLOGY, COMPLEX (MHC I/PEPTIDE/CD8)
2b1h:H (PRO151) to (PRO227) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE | FAB-PEPTIDE COMPLEX; HIV-1; GP120; V3 LOOP, IMMUNE SYSTEM
3rzc:A (PRO217) to (TRP279) STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3ejy:E (PRO157) to (PRO220) STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER, CLC-EC1 | MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX
1nsn:H (PRO151) to (LYS221) THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN, STAPHYLOCOCCAL NUCLEASE, COMPLEX (IMMUNOGLOBULIN/HYDROLASE) COMPLEX
1b0g:A (GLU212) to (TRP274) CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX | CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)-BETA 2-MICROGLOBULIN- PEPTIDE P1049 COMPLEX, HISTOCOMPATIBILITY ANTIGEN
1b0g:D (GLU212) to (TRP274) CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX | CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)-BETA 2-MICROGLOBULIN- PEPTIDE P1049 COMPLEX, HISTOCOMPATIBILITY ANTIGEN
4wu5:A (GLU212) to (TRP274) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT) | IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I
4wu5:D (GLU212) to (TRP274) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT) | IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I
4wu7:D (GLU212) to (TRP274) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(2F) | IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I
1o0v:A (ASP473) to (VAL543) THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION | IGE FC, IMMUNOGLOBULIN E, IMMUNE SYSTEM
1o0v:B (ASP473) to (VAL543) THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION | IGE FC, IMMUNOGLOBULIN E, IMMUNE SYSTEM
2p5w:A (ASP227) to (TRP274) CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
3eyq:D (PRO161) to (GLU224) CRYSTAL STRUCTURE OF MJ5 FAB, A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 | HUMAN CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4hkj:A (ASP212) to (TRP274) STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB) | VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4hkj:E (ASP212) to (TRP274) STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB) | VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4hkj:I (ASP212) to (TRP274) STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB) | VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4hkj:M (ASP212) to (TRP274) STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB) | VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3s4d:A (GLY112) to (GLU190) LACTOSE PHOSPHORYLASE IN A TERNARY COMPLEX WITH CELLOBIOSE AND SULFATE | GH94, ALPHA BARREL, LACTOSE PHOSPHORYLASE, DISACCHARIDE PHOSPHORYLASE, TRANSFERASE
1bii:A (ASP212) to (TRP274) THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110 | COMPLEX (MHC I/PEPTIDE), MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I DD, TRANSMEMBRANE, GLYCOPROTEIN
1bln:B (GLY169) to (PRO227) ANTI-P-GLYCOPROTEIN FAB MRK-16 | IMMUNOGLOBULIN, IMMUNE SYSTEM
1bln:D (GLY169) to (PRO227) ANTI-P-GLYCOPROTEIN FAB MRK-16 | IMMUNOGLOBULIN, IMMUNE SYSTEM
2bnq:A (GLU212) to (TRP274) STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES | IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR, SUPERAGONIST PEPTIDE T-CELL VACCINES
3s62:H (PRO151) to (PRO214) STRUCTURE OF FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 AGAINST P. VIVAX P25 PROTEIN | TYPICAL ANTIBODY FOLD, IMMUNE SYSTEM
1bqh:A (ASP212) to (TRP274) MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8 | T-CELL, CORECEPTOR, GLYCOPROTEIN, COMPLEX, IMMUNOLOGY, ANTIGEN, IMMUNE SYSTEM
3s7g:A (PRO271) to (LYS338) AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT | AGLYCOSYLATED, FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN
3s7g:B (PRO271) to (LYS338) AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT | AGLYCOSYLATED, FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN
3s7g:C (PRO271) to (LYS338) AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT | AGLYCOSYLATED, FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN
3s7g:D (PRO271) to (LYS338) AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT | AGLYCOSYLATED, FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN
2bsr:A (GLU212) to (TRP274) CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 | IMMUNE SYSTEM/PEPTIDE, MHC, HLA-B27, HUMAN EBV, HIV, GLYCOPROTEIN, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, NUCLEAR PROTEIN, COMPLEX (ANTIGEN/PEPTIDE)
2bst:A (GLU212) to (TRP274) CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 | IMMUNE SYSTEM-PEPTIDE COMPLEX, MHC, HLA-B27, HUMAN EBV, HIV, FLU, GLYCOPROTEIN, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, COMPLEX (ANTIGEN/PEPTIDE), VIRAL NUCLEOPROTEIN
4hqq:L (GLY142) to (ALA207) CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58 | IMMUNOGLOBULIN, IMMUNE SYSTEM
4xbg:J (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
2bvo:A (GLU212) to (TRP274) STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION | GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP HIV-1, GLYCOPROTEIN/PEPTIDE COMPLEX, MHC I, POLYMORPHISM, SIGNAL, TRANSMEMBRANE, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID
2bvp:A (GLU212) to (TRP274) STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION | GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP, HIV-1, GLYCOPROTEIN, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, IMMUNE RESPONSE
4hv8:A (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H2DB-H155A-NPM6I | VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM
3scm:A (PRO217) to (TYR278) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE | TERNARY COMPLEX, IMMUNITY, APC CELL SURFACE, IMMUNE SYSTEM
4hwz:A (ASP227) to (TRP274) STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV DERIVED PEPTIDE | HLA MOLECULES, PEPTIDE PRESENTATION, IMMUNE SYSTEM
4hx1:A (ASP227) to (TRP274) STRUCTURE OF HLA-A68 COMPLEXED WITH A TUMOR ANTIGEN DERIVED PEPTIDE | HLA MOLECULES, PEPTIDE PRESENTATION, IMMUNE SYSTEM
3sdc:A (PRO217) to (TRP279) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE | CD1D, AUTOIMMUNITY, SELF-RECOGNITION, NKT, IMMUNE SYSTEM
3ffc:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR | TCR-PEPTIDE-MHC, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ffc:F (GLU212) to (TRP274) CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR | TCR-PEPTIDE-MHC, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1oga:A (GLU212) to (TRP274) A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION. | IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR
1ogt:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) | IMMUNE SYSTEM/COMPLEX, IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2705
1c5b:H (GLY169) to (PRO227) DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, DECARBOXYLASE, UNLIGANDED, IMMUNE SYSTEM
4i2x:B (GLY168) to (PRO218) CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117 | PROTEIN-FAB COMPLEX, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, SIGNAL REGULATORY PROTEIN, CD47, CELL SURFACE, IMMUNE SYSTEM
2pr4:H (PRO168) to (PRO232) CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 | NMAB 2F5, GP41, HIV, VIRAL PROTEIN
1cd1:A (PRO217) to (TYR278) CD1(MOUSE) ANTIGEN PRESENTING MOLECULE | CD1, IMMUNOLOGY, MHC, TCR, GLYCOPROTEIN, SIGNAL, IMMUNOGLOBULIN FOLD, T-CELL
1cd1:C (PRO217) to (TYR278) CD1(MOUSE) ANTIGEN PRESENTING MOLECULE | CD1, IMMUNOLOGY, MHC, TCR, GLYCOPROTEIN, SIGNAL, IMMUNOGLOBULIN FOLD, T-CELL
1ce6:A (ASP212) to (TRP274) MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE | MHC CLASS I, ANTIGEN PRESENTATION, VIRAL PEPTIDE, COMPLEX
4i4w:A (ASP227) to (ARG273) PEPTIDE LENGTH DETERMINES THE OUTCOME OF T CELL RECEPTOR/PEPTIDE-MHCI ENGAGEMENT | MHC I FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, IMMUNE SYSTEM
3sko:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE HLA-B8-A66-FLR, MUTANT A66 OF THE HLA B8 | T CELL RECEPTOR, IMMUNE SYSTEM, ANTIGEN PRESENTATION
1cfn:B (GLY161) to (PRO211) ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-RELATED PEPTIDE | POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1
1cg9:A (GLU212) to (ARG273) COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 | MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/ PEPTIDE), SFR8-B6 EPITOPE
3fom:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE IQQSIERL | CLASS I MHC, PEPTIDE COMPLEX, DIABETES-PROTECTIVE EFFECT, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, IMMUNE SYSTEM
3fon:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI | CLASS I MHC, PEPTIDE COMPLEX, DIABETES-PROTECTIVE EFFECT, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, IMMUNE SYSTEM
3fon:C (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI | CLASS I MHC, PEPTIDE COMPLEX, DIABETES-PROTECTIVE EFFECT, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, IMMUNE SYSTEM
1orq:B (PRO154) to (PRO217) X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB | POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, KVAP, FAB COMPLEX, MEMBRANE PROTEIN
3fqt:A (ASP227) to (TRP274) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
3fqu:A (ASP227) to (TRP274) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
1osz:A (ASP212) to (TRP274) MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN | MHC/PEPTIDE COMPLEX, TRANSMEMBRANE PROTEIN, THYMIC SELECTION, COMPLEX (MHC I/PEPTIDE)
3fru:A (GLU209) to (LEU269) NEONATAL FC RECEPTOR, PH 6.5 | COMPLEX (IMMUNOGLOBULIN-BINDING PROTEIN), COMPLEX (IMMUNOGLOBULIN- BINDING PROTEIN) COMPLEX
1cr9:H (GLY159) to (PRO209) CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 | ANTI-PRION ANTIBODY, FAB 3F4, IMMUNE SYSTEM
4icx:A (LYS25) to (LEU99) N-TERMINAL C2 DOMAIN OF HUMAN CEP120 | C2 DOMAIN, LIPID BINDING, TRANSPORT PROTEIN
2c7u:A (GLU212) to (TRP274) CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. | GLYCOPROTEIN-PEPTIDE COMPLEX, MHC, TCR, HLA-A2, HIV, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, AIDS
2c7u:D (GLU212) to (TRP274) CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. | GLYCOPROTEIN-PEPTIDE COMPLEX, MHC, TCR, HLA-A2, HIV, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, AIDS
1ct8:D (GLY162) to (PRO212) CATALYTIC ANTIBODY 7C8 COMPLEX | ABZYME TRANSITION STATE ANALOG, IMMUNE SYSTEM
1cwp:A (GLY103) to (GLU176) STRUCTURES OF THE NATIVE AND SWOLLEN FORMS OF COWPEA CHLOROTIC MOTTLE VIRUS DETERMINED BY X-RAY CRYSTALLOGRAPHY AND CRYO-ELECTRON MICROSCOPY | BROMOVIRUS, ICOSAHEDRAL VIRUS, VIRUS/RNA COMPLEX
1cwp:B (THR104) to (GLU176) STRUCTURES OF THE NATIVE AND SWOLLEN FORMS OF COWPEA CHLOROTIC MOTTLE VIRUS DETERMINED BY X-RAY CRYSTALLOGRAPHY AND CRYO-ELECTRON MICROSCOPY | BROMOVIRUS, ICOSAHEDRAL VIRUS, VIRUS/RNA COMPLEX
1cwp:C (THR104) to (GLU166) STRUCTURES OF THE NATIVE AND SWOLLEN FORMS OF COWPEA CHLOROTIC MOTTLE VIRUS DETERMINED BY X-RAY CRYSTALLOGRAPHY AND CRYO-ELECTRON MICROSCOPY | BROMOVIRUS, ICOSAHEDRAL VIRUS, VIRUS/RNA COMPLEX
4xnz:B (PRO156) to (PRO220) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC06B IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
2qad:C (LYS145) to (ARG211) STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4 | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2qad:G (LYS145) to (ARG211) STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4 | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4xp1:H (PRO155) to (PRO218) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO NEUROTRANSMITTER DOPAMINE | INTEGRAL MEMBRANE PROTEIN, MEMBRANE PROTEIN-TRANSPORT PROTEIN COMPLEX
4xph:H (GLY168) to (PRO218) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO 3,4DICHLOROPHENETHYLAMINE | INTEGRAL MEMBRANE PROTEIN, NEUROTRANSMITTER TRANSPORTER, PROTEIN TRANSPORT-INHIBITOR COMPLEX
1p7k:H (GLY162) to (PRO212) CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES) | FAB, ANTIBODY, ANTI-DNA ANTIBODY, AUTOANTIBODY, LUPUS, HEPES, IMMUNE SYSTEM
1p7q:A (GLU212) to (ARG273) CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR | HLA-A2/LIR-1 COMPLEX, IMMUNE SYSTEM
1dbb:H (PRO151) to (PRO227) THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX | IMMUNOGLOBULIN
2cii:A (ASP212) to (TRP274) THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY- INTERMEDIATE | IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIGEN/PEPTIDE), MHC CLASS I, PEPTIDE BINDING, SENDAI VIRUS, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN, MEMBRANE, TRANSMEMBRANE
2cik:A (GLU212) to (TRP274) INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450. | IMMUNE SYSTEM/PEPTIDE, ANTIGEN/PEPTIDE COMPLEX, MAJOR HISTOCOMPATIBILITY ANTIGEN, HUMAN, MHC, HLA, HLA-B3501, EBV, ALLO-LIGAND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID
2clr:A (GLU212) to (TRP274) THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE | HISTOCOMPATIBILITY ANTIGEN
2clr:D (GLU212) to (TRP274) THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE | HISTOCOMPATIBILITY ANTIGEN
2clz:A (ASP212) to (TRP274) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE | IMMUNE RESPONSE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN, TRANSMEMBRANE, ALLOREACTIVITY, MHC I, H-2KBM8, MEMBRANE, CLASS I MHC, POLYMORPHISM
4iof:D (ALA145) to (ARG212) CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) | HYDROLASE, ZINC METALLOPROTEASE
3gbm:L (GLY158) to (PRO211) CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ. | HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, AVIAN FLU, ENVELOPE PROTEIN, FUSION PROTEIN, VIRAL PROTEIN - IMMUNE SYSTEM COMPLEX
4irs:A (PRO217) to (TRP279) STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4xvu:C (GLY171) to (PRO222) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xwo:V (ALA147) to (ARG214) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xwo:X (ALA147) to (ASN213) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xxc:A (GLU212) to (TRP274) HLA-B*1801 IN COMPLEX WITH A SELF-PEPTIDE, DELEIKAY | EBV, HLA, TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
2qrt:B (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C, BETA- 2MICROGLOBULIN, AND OVALBUMIN-DERIVED PEPTIDE. | MHC-I, OVA, SINGLE CHAIN MHC-I, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM
3ghe:H (PRO149) to (LEU213) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 537-10D IN COMPLEX WITH V3 PEPTIDE MN | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM
1duz:D (GLU212) to (TRP274) HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3giv:A (GLU212) to (TRP274) ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE | HIV, MHC, ESCAPE, ANTIGEN, IMMUNE RECOGNITION, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED', IMMUNE SYSTEM
1psk:H (PRO150) to (LYS209) THE CRYSTAL STRUCTURE OF AN FAB FRAGMENT THAT BINDS TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE | FAB, GD2-GANGLIOSIDE, CARBOHYDRATE, MELANOMA, IMMUNOGLOBULIN
2d31:D (GLY207) to (TRP274) CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER | MHC CLASS I, IMMUNE SYSTEM/CELL CYCLE COMPLEX
3gmm:A (PRO217) to (TRP279) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
3gmn:A (PRO217) to (TRP279) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
3gmp:A (PRO217) to (TRP279) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25 | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
3gmq:A (PRO217) to (TRP279) STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS, NO LIGAND ADDED | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
1e27:A (GLU212) to (TRP274) NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI) | IMMUNE SYSTEM, HLA B51, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
1e28:A (GLU212) to (TRP274) NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2(TAFTIPSI) | HLA B51, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
4y4f:A (PRO217) to (TRP279) CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR
2r0l:L (LYS145) to (ASN210) SHORT FORM HGFA WITH INHIBITORY FAB75 | SERINE PROTEASE, ANTIBODY, ALLOSTERIC INHIBITOR, EGF-LIKE DOMAIN, GLYCOPROTEIN, HYDROLASE, KRINGLE, SECRETED, ZYMOGEN, IMMUNE SYSTEM
3tbs:A (ASP212) to (ARG273) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX THE WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P,Y4A) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tbs:D (ASP212) to (ARG273) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX THE WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P,Y4A) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tbv:C (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G,V3P,Y4A) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tbw:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G, V3P, Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tbw:C (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G, V3P, Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tby:A (ASP212) to (ARG273) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4F) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tby:D (ASP212) to (ARG273) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4F) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tby:G (ASP212) to (ARG273) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4F) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tby:J (ASP212) to (ARG273) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4F) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tcl:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04 | IG, IMMUNOGLOBULIN, IMMUNE SYSTEM
2r4s:H (GLY162) to (PRO212) CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR | TRANSMEMBRANE HELIX, G-PROTEIN COUPLED RECEPTOR, GLYCOPROTEIN, LIPOPROTEIN, PALMITATE, PHOSPHORYLATION, RECEPTOR, TRANSDUCER, SIGNALING PROTEIN
2r56:L (ALA144) to (ARG211) CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN | ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM
2r56:M (ALA144) to (ARG211) CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN | ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM
2r56:I (PRO157) to (PRO221) CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN | ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM
1e6o:H (GLY169) to (PRO219) CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24 | IMMUNOGLOBULIN, FAB, ANTIBODY, ANTIGEN, HIV-1, P24, CA
1pzd:A (VAL677) to (VAL752) STRUCTURAL IDENTIFICATION OF A CONSERVED APPENDAGE DOMAIN IN THE CARBOXYL-TERMINUS OF THE COPI GAMMA-SUBUNIT. | PLATFORM DOMAIN, APPENDAGE DOMAIN, EAR DOMAIN, ENDOCYTOSIS/EXOCYTOSIS COMPLEX
3thm:H (PRO168) to (PRO232) CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01 | AGONISTIC ANTIBODY, FAB FRAGMENT, ANTIBODY-RECEPTOR COMPLEX, TUMOR NECROSIS FACTOR RECEPTOR, CYSTEINE-RICH DOMAIN, FAS, IMMUNE SYSTEM
1ed3:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E. | MAJOR HISTOCOMPATIBILITY COMPLEX, RAT MINOR HISTOCOMPATIBILITY COMPLEX, MHC, IMMUNOLOGY, PEPTIDE ANTIGEN PRESENTATION, CELLULAR IMMUNITY, CELL SURFACE RECEPTOR, T CELL RECEPTOR LIGAND, IMMUNE SYSTEM
1ed3:D (ASP212) to (TRP274) CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E. | MAJOR HISTOCOMPATIBILITY COMPLEX, RAT MINOR HISTOCOMPATIBILITY COMPLEX, MHC, IMMUNOLOGY, PEPTIDE ANTIGEN PRESENTATION, CELLULAR IMMUNITY, CELL SURFACE RECEPTOR, T CELL RECEPTOR LIGAND, IMMUNE SYSTEM
4jdv:A (GLY166) to (PRO217) CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB | IG FOLD, ANTI HIV ANTIBODY, IMMUNE SYSTEM
1eey:A (GLU212) to (TRP274) CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V) | MAJOR HISTICOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM
1eey:D (GLU212) to (TRP274) CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V) | MAJOR HISTICOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM
1eez:D (GLU212) to (TRP274) CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L) | MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM
1q9o:D (GLY160) to (PRO210) S45-18 FAB UNLIGANDED | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
1efx:A (ILE213) to (TRP274) STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 | MHC, HLA, CLASS I, KIR, NK CELL RECEPTOR, IMMUNOGLOBULIN FOLD, RECEPTOR/MHC COMPLEX, IMMUNE SYSTEM
4jfo:A (GLU212) to (TRP274) A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY
4jfo:D (ILE213) to (TRP274) A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY
4jfq:A (GLU212) to (TRP274) A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY
2dtm:L (ASN145) to (ASN210) THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES | CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM
1qew:A (GLU212) to (TRP274) HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279) | COMPLEX (MHC PROTEINTIGEN), HISTOCOMPATIBILITY ANTIGEN
4yfl:I (VAL144) to (PRO208) CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 1B2530 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120 | HIV-1 CD4 BINDING SITE, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
1qlf:A (ASP212) to (TRP274) MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G | IMMUNE SYSTEM/PEPTIDE, MURINE CLASS I MHC/PEPTIDE COMPLEX, MHC, GLYCOPEPTIDE, ANTIGEN, HISTOCOMPATIBILITY, IMMUNOLOGY
3tv3:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9 | FAB, HIV-1 NEUTRALIZING ANTIBODY, GP120, IMMUNE SYSTEM
1qo3:A (ASP212) to (TRP274) COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD | RECEPTOR/IMMUNE SYSTEM, COMPLEX (NK RECEPTOR/MHC CLASS I), NK CELL, INHIBITORY RECEPTOR, MHC-I, C-TYPE LECTIN-LIKE, HISTOCOMPATIBILITY, B2M, LY49, LY-49
4jpi:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB | ANTI-HIV-1, GP120, CD4 BINDING SITE-TARGETING, VRC01 BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
4jqv:A (GLU212) to (TRP274) HLA-B*18:01 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 173-180) | IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, EXTRACELLULAR, IMMUNE SYSTEM
4jqx:A (GLU212) to (TRP274) HLA-B*44:03 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 169-180) | IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, EXTRACELLULAR, IMMUNE SYSTEM
4jry:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX | TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM
3tyg:H (VAL152) to (LYS228) CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH A GLYCOSYLATED ENGINEERED GP120 OUTER DOMAIN WITH MINIV3 (EODMV3) | GP120, HIV-1, ENV, FAB, HIV-1 NEUTRALIZING ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN
1qse:A (GLU212) to (TRP274) STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R | HUMAN T CELL RECEPTOR, TCR/PEPTIDE/MHC COMPLEX, HLA-A2, IMMUNE SYSTEM
1qvo:A (ILE213) to (TRP274) STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE | IMMUNE SYSTEM
1qvo:D (GLU212) to (TRP274) STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE | IMMUNE SYSTEM
3h9h:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE | TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3h9h:D (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE | TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3h9s:A (GLU212) to (TRP274) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE | TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3h9y:A (ASP473) to (VAL543) CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS | IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3h9y:B (ASP473) to (VAL543) CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS | IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3h9y:E (VAL370) to (THR434) CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS | IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3h9y:E (ASP473) to (ASN544) CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS | IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3ha0:A (ASP473) to (VAL543) CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS | IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3ha0:B (ASP473) to (VAL543) CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS | IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3ha0:C (LYS367) to (THR434) CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS | IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1f6a:D (VAL370) to (LYS435) STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA) | IMMUNOGLOBULIN FOLD, GLYCOPROTEIN, RECEPTOR, IGE-BINDING PROTEIN, IGE ANTIBODY, IGE-FC, IMMUNE SYSTEM
4jvu:A (PRO266) to (SER335) IGM C2-DOMAIN FROM MOUSE | IMMUNOGLOBULIN M, ANTIBODY, OLIGOMERIZATION, IMMUNOGLOBULIN FOLD, RECEPTOR, PROTEIN BINDING
3hcv:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) | IMMUNE SYSTEM/COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX) I, HLA-B*2709, GLYCOPROTEIN, HOST-VIRUS, IMMUNE RESPONSE, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, SECRETED, DISULFIDE BOND, MHC I
4jy4:A (ALA144) to (ALA208) CRYSTAL STRUCTURE OF HUMAN FAB PGT121, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | BROADLY NEUTRALIZING ANTIBODY AGAINST HIV-1, HIV-1 ENV GP120 SUBUNIT, IMMUNE SYSTEM
4jy6:B (PRO147) to (PRO211) CRYSTAL STRUCTURE OF HUMAN FAB PGT123, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | BROADLY NEUTRALIZING ANTIBODY AGAINST HIV-1, HIV-1 ENV GP120 SUBUNIT, IMMUNE SYSTEM
4jy6:C (THR146) to (ALA208) CRYSTAL STRUCTURE OF HUMAN FAB PGT123, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | BROADLY NEUTRALIZING ANTIBODY AGAINST HIV-1, HIV-1 ENV GP120 SUBUNIT, IMMUNE SYSTEM
1ffp:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S) | MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, T CELL RECEPTOR, CRYSTALLOGRAPHY, IMMUNE SYSTEM/SIGNALING PROTEIN COMPLEX
1ffp:D (ASP212) to (TRP274) CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S) | MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, T CELL RECEPTOR, CRYSTALLOGRAPHY, IMMUNE SYSTEM/SIGNALING PROTEIN COMPLEX
1fh5:H (PRO151) to (PRO214) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MONOCLONAL ANTIBODY MAK33 | FAB, BIP, IMMUNE SYSTEM
4ypg:B (GLY165) to (PRO216) STRUCTURAL INSIGHTS INTO THE NEUTRALIZATION PROPERTIES OF A HUMAN ANTI-INTERFERON MONOCLONAL ANTIBODY | THERAPEUTIC MAB, IFN-ALPHA2A
2v2x:A (GLU212) to (TRP274) T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT. | IMMUNE SYSTEM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, MHC TCR HLA-A2 HIV, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, POLYMORPHISM, GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID
2v2x:D (GLU212) to (TRP274) T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT. | IMMUNE SYSTEM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, MHC TCR HLA-A2 HIV, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, POLYMORPHISM, GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID
1fj1:B (GLU148) to (SER213) LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2 | OSPA, LYME DISEASE, ANTIBODY FAB FRAGMENT, NEUTRALIZING EPITOPE, IMMUNE SYSTEM
4yr6:D (PRO158) to (ALA221) FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE | GPIBA SHEDDING INHIBITOR, 5G6, KL10, IMMUNE SYSTEM
1fo0:H (ASP212) to (TRP274) MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX | T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, IMMUNE SYSTEM
2exw:E (PRO157) to (PRO220) CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS | CLC FAMILY OF CL- CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX
4k7f:D (GLU212) to (TRP274) NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201 | HOST-VIRUS INTERACTION, IMMUNE RESPONSE, DISEASE MUTATION, VIRAL REPLICATION, IG-LIKE DOMAIN, IMMUNE SYSTEM, TCR, MEMBRANE GLYCOPROTEIN, VIRAL CAPSID PROTEIN
1rhh:D (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION | FAB, ANTIBODY, X5, HIV-1, BROADLY NEUTRALIZING, IMMUNE SYSTEM
2vaa:A (ASP212) to (TRP274) MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN | HISTOCOMPATIBILITY ANTIGEN, CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC I, MHC-PEPTIDE COMPLEX, COMPLEX (MHC I/PEPTIDE) COMPLEX
2vab:A (ASP212) to (TRP274) MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN | HISTOCOMPATIBILITY ANTIGEN, CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC I, MHC-PEPTIDE COMPLEX, COMPLEX (MHC I/PEPTIDE) COMPLEX
1rjz:A (ASP212) to (TRP274) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE | MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM
1rjz:D (ASP212) to (TRP274) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE | MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM
1rk1:A (ASP212) to (TRP274) MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE | MHC, CLASS I, VIRUS, TCR, HERPES, IMMUNE SYSTEM
3ulu:L (LYS145) to (ASN210) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1) | TOLL-LIKE RECEPTOR-3, TLR3,INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
2f53:A (GLU212) to (TRP274) DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
2f54:F (GLU212) to (TRP274) DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, WILD TYPE SEQUENCE, HIGH AFFINITY, NY-ESO-1, IMMUNE SYSTEM
2f5a:H (PRO168) to (PRO232) CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 | FAB, HIV-1 NEUTRALIZATION, GP41, IMMUNOGLOBULIN
2f74:A (ASP212) to (TRP274) MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM
2f74:D (ASP212) to (ARG273) MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM
1fzj:A (ASP212) to (TRP274) MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN | MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM
1fzk:A (ASP212) to (TRP274) MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN | MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM
1fzm:A (ASP212) to (TRP274) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN | MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM
2fat:H (PRO144) to (ALA207) AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE | ANTI-UPAR ANTIBODY, ATN-615, FAB, CRYSTAL STRUCTURE, IMMUNE SYSTEM
2fec:L (ASN144) to (ALA211) STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI | CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN
2fee:I (PRO157) to (PRO220) STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR | CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN
2fed:E (GLY170) to (PRO220) STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI | CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN
2ve6:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE | PHOTOCLEAVABLE PEPTIDE, AUXILIARY ANCHORING RESIDUE, GLYCOPROTEIN, TRANSMEMBRANE, PEPTIDE LOADING, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, MHC, SEV9, MHC I, MEMBRANE, SECRETED
2ve6:D (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE | PHOTOCLEAVABLE PEPTIDE, AUXILIARY ANCHORING RESIDUE, GLYCOPROTEIN, TRANSMEMBRANE, PEPTIDE LOADING, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, MHC, SEV9, MHC I, MEMBRANE, SECRETED
1g7p:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE | MHC CLASS I, H-2KB, YEAST, S. CEREVISIAE, ALPHA-GLUCOSIDASE, IMMUNE SYSTEM
1g7q:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA | MHC CLASS I, H-2KB, MUC1, VNTR, MUCIN, IMMUNE SYSTEM
1rzf:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51 | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:C (ALA144) to (ASN210) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
3hpj:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE | WT-1, WT1, WT126 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3hpj:D (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE | WT-1, WT1, WT126 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
4z5r:A (LYS145) to (ARG211) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
2vit:B (PRO158) to (PRO221) INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 155 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY | COMPLEX (HEMAGGLUTININ/IMMMUNOGLOBULIN), GLYCOPROTEIN
4kkb:E (GLY170) to (PRO220) STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE | MEMBRANE TRANSPORTER, TRANSPORT PROTEIN
4z76:A (ASP212) to (TRP274) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z76:D (ASP212) to (TRP274) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z77:A (ASP212) to (TRP274) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z78:A (ASP212) to (TRP274) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z78:D (ASP212) to (TRP274) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
4z78:G (ASP212) to (TRP274) WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES | IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM
2vjx:B (LYS722) to (ARG777) STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES | LINEAR FREE ENERGY RELATIONSHIP, HYDROLASE, TRANSITION STATE MIMIC, MANNOSIDASE, GLYCOSIDE HYDROLASE
4z8f:H (SER149) to (LYS209) FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA, 5'-P5(DT)P- 3' | ANTIBODY, FAB, CARBOHYDRATE, LIPID A, DNA, IMMUNE SYSTEM-DNA COMPLEX
4z95:H (SER149) to (PRO212) FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA, 5'-5(DT)-P- 3' | ANTIBODY, FAB, CARBOHYDRATE, LIPID A, DNA, IMMUNE SYSTEM, IMMUNE SYSTEM-DNA COMPLEX
4z95:L (ILE144) to (ASN210) FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA, 5'-5(DT)-P- 3' | ANTIBODY, FAB, CARBOHYDRATE, LIPID A, DNA, IMMUNE SYSTEM, IMMUNE SYSTEM-DNA COMPLEX
2fo4:A (ASP212) to (TRP274) ENHANCED MHC CLASS I BINDING AND IMMUNE RESPONSES THROUGH ANCHOR MODIFICATION OF THE NON-CANONICAL TUMOR ASSOCIATED MUC1-8 PEPTIDE | ANCHOR MODIFICATIONS, H-2KB, MUC1, NON-CANONICAL PEPTIDE, MUC1-8, VACCINE DESIGN, IMMUNE SYSTEM
4zak:A (PRO217) to (TRP279) CRYSTAL STRUCTURE OF THE MCD1D/DB06-1/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM
1s7q:A (ASP212) to (TRP274) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s7t:A (ASP212) to (TRP274) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s7u:D (ASP212) to (TRP274) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s7u:G (ASP212) to (TRP274) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s7u:J (ASP212) to (TRP274) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s7w:A (ASP212) to (TRP274) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s7w:G (ASP212) to (TRP274) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s7x:A (ASP212) to (ARG273) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s7x:D (ASP212) to (ARG273) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s7x:G (ASP212) to (ARG273) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s7x:J (ASP212) to (TRP274) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
1s8d:A (ASP227) to (TRP274) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE- MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1s9w:A (GLU212) to (TRP274) CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC, IN COMPLEX WITH HLA-A2 | IMMUNE SYSTEM
1s9x:A (GLU212) to (TRP274) CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQA, IN COMPLEX WITH HLA-A2 | IMMUNE SYSTEM
1s9y:A (GLU212) to (TRP274) CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2 | IMMUNE SYSTEM
1sbs:L (ASN151) to (ASN216) CRYSTAL STRUCTURE OF AN ANTI-HCG FAB | MONOCLONAL ANTIBODY, FAB-FRAGMENT, REPRODUCTION
2vl4:A (LYS722) to (ARG777) STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES | LINEAR FREE ENERGY RELATIONSHIP, HYDROLASE, TRANSITION STATE MIMIC, MANNOSIDASE, GLYCOSIDE HYDROLASE
2vl4:B (ILE723) to (ARG777) STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES | LINEAR FREE ENERGY RELATIONSHIP, HYDROLASE, TRANSITION STATE MIMIC, MANNOSIDASE, GLYCOSIDE HYDROLASE
1seq:H (GLY162) to (PRO212) FAB MNAC13 | IMMUNOGLOBULIN, IMMUNE SYSTEM
2vlj:A (GLU212) to (TRP274) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX
2vll:A (GLU212) to (TRP274) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, POLYMORPHISM, TCR, FLU, MHC, MHC I, T-CELL, PEPTIDE, COMPLEX
2vll:D (GLU212) to (TRP274) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, POLYMORPHISM, TCR, FLU, MHC, MHC I, T-CELL, PEPTIDE, COMPLEX
3v5d:A (GLU212) to (TRP274) HLA-A2.1 KVAELVHFL | PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM
3v5d:D (GLU212) to (TRP274) HLA-A2.1 KVAELVHFL | PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM
3v5k:D (GLU212) to (TRP274) HLA2.1 KVAELVWFL | PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM
3hzm:B (GLY161) to (PRO211) CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
2fyy:A (GLU212) to (TRP274) THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION | MHC, HLA-B*3501, IG DOMAIN, IMMUNE SYSTEM
2fz3:A (GLU212) to (TRP274) THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION | MHC, HLA-B*3508, IG DOMAIN, IMMUNE SYSTEM
3i02:D (PRO149) to (ILE210) CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
2vq1:F (PRO149) to (ARG209) ANTI TRIMERIC LEWIS X FAB54-5C10-A | MONOCLONAL ANTIBODY, RECEPTOR, DIAGNOSIS, SCHISTOSOMIASIS, CARBOHYDRATE RECOGNITION, IMMUNE SYSTEM
3v95:B (ASP270) to (LYS338) CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA | FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM
2vqu:A (ILE723) to (ARG777) STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES | LINEAR FREE ENERGY RELATIONSHIP, TRANSITION STATE MIMIC, MANNOSIDASE, GLYCOSIDE HYDROLASE, HYDROLASE
2vqt:A (LYS722) to (ARG777) STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES | LINEAR FREE ENERGY RELATIONSHIP, TRANSITION STATE MIMIC, HYDROLASE, MANNOSIDASE, GLYCOSIDE HYDROLASE
2vqt:B (LYS722) to (ARG777) STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES | LINEAR FREE ENERGY RELATIONSHIP, TRANSITION STATE MIMIC, HYDROLASE, MANNOSIDASE, GLYCOSIDE HYDROLASE
4kuc:H (PRO176) to (PRO237) CRYSTAL STRUCTURE OF RICIN-A CHAIN IN COMPLEX WITH THE ANTIBODY 6C2 | RNA-N-GLYCOSIDASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
3vcl:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B7 WITH THE HCMV PP65 PEPTIDE RPHERNGFTVL | CLASS I HISTOCOMPATIBILITY ANTIGEN, ANTIGEN PRESENTATION, T-CELL RECEPTOR, MEMBRANE, IMMUNE SYSTEM
4kvn:H (PRO161) to (LYS222) CRYSTAL STRUCTURE OF FAB 39.29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/PERTH/16/2009 (H3N2) | IGG, ANTIBODY, IMMUNE SYSTEM
3i6g:A (GLU212) to (TRP274) NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201 | HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
3i6g:D (GLU212) to (TRP274) NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201 | HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
3i6k:A (GLU212) to (TRP274) NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201 | HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
3i6k:E (GLU212) to (TRP274) NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201 | HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
1sys:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY | HLA, MHC, CLASS I, B44, IMMUNE SYSTEM
1syv:A (GLU212) to (TRP274) HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF | HLA, MHC, CLASS I, B44, IMMUNE SYSTEM
3vfm:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508 LPEP155A, HLA MUTANT ALA155 | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfn:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508LPEP151A, HLA MUTANT ALA151 | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfo:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508 LPEP157A, HLA MUTANT ALA157 | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfp:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508 LPEP158G, HLA MUTANT GLY158 | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfr:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508LPEP-P4ALA, PEPTIDE MUTANT P4-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfs:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508LPEP-P5ALA , PEPTIDE MUTANT P5-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vft:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508LPEP-P6ALA, PEPTIDE MUTANT P6-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfu:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P7ALA, PEPTIDE MUTANT P7-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfv:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P9ALA, PEPTIDE MUTANT P9-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
3vfw:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P10ALA, PEPTIDE MUTANT P10-ALA | HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE
1t04:B (PRO153) to (PRO217) THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP | ANTIBODY ENGINEERING, HUMANIZED AND CHIMERIC ANTIBODY, FAB, X-RAY STRUCTURE, THREE-DIMENSIONAL STRUCTURE, GAMMA- INTERFERON, IMMUNE SYSTEM
3vh8:A (GLU212) to (TRP274) KIR3DL1 IN COMPLEX WITH HLA-B*5701 | IMMUNOGLOBULIN FOLD, NATURAL KILLER CELL RECEPTOR, IMMUNE SYSTEM
1t1w:A (ASP227) to (TRP274) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1t1x:A (ASP227) to (TRP274) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1t1z:A (ASP227) to (TRP274) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1t20:A (ASP227) to (TRP274) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1t21:A (ASP227) to (TRP274) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
2git:D (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K- 4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE | HTLV-1 TAX PEPTIDE, HAPTENATED PEPTIDE, LYSINE-4-(3-INDOLYL)-BUTYRIC ACID, MHC CLASS I,HLA-A2, IMMUNE SYSTEM
3vj6:A (ASP212) to (TRP274) STRUCTURE OF THE MHC CLASS IB MOLECULE QA-1B | MHC-CLASSIB, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, PEPTIDE PRESENTATION, CD94-NKG2A/C RECEPTORS
4l5f:H (GLY162) to (SER212) CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII | ANTIBODY, FAB, NEUTRALIZING, VIRUS, ENVELOPE, VIRAL PROTEIN, IMMUNE SYSTEM, ANTIBODY EPITOPE, INFECTIOUS DISEASE, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID), NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
1t66:D (GLY167) to (PRO217) THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN. | ANTIBODY, FAB, FLUORESCEIN, IMMUNE SYSTEM
4l8c:C (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE | INFLUENZA, VIRAL ESCAPE, T CELL IMMUNITY, IMMUNE SYSTEM
2gsi:B (PRO151) to (PRO227) CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE | FAB, IGG, STAPHYLOCOCCAL NUCLEASE, IMMUNE SYSTEM
3ijh:B (PRO149) to (ARG209) STRUCTURE OF S67-27 IN COMPLEX WITH KO | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
3ijh:C (ASN144) to (ASN211) STRUCTURE OF S67-27 IN COMPLEX WITH KO | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
3ijs:A (ASN144) to (ASN209) STRUCTURE OF S67-27 IN COMPLEX WITH TSBP | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
3ijy:C (ASN144) to (ASN209) STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
3ijy:D (PRO149) to (PRO212) STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
2gtz:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION | MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A28L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
2guo:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN- A/MART-1(27-35) PEPTIDE | MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
4lcy:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B46 AT 1.6 ANGSTROM RESOLUTION | ANTIGEN PRESENTING, CELL SURFACE, HLA-B46, MEMBRANE PROTEIN
4lf3:B (PRO378) to (PRO442) INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR | FAB FRAGMENT, GCGR, IMMUNE SYSTEM
4lf3:E (PRO378) to (GLU441) INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR | FAB FRAGMENT, GCGR, IMMUNE SYSTEM
4zus:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE REV-QW11 | LENTIVIRUS VACCINE, IMMUNE SYSTEM
4zuv:A (ILE213) to (TRP274) CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12 | LENTIVIRUS VACCINE, IMMUNE SYSTEM
4zuv:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12 | LENTIVIRUS VACCINE, IMMUNE SYSTEM
2h1p:H (PRO456) to (PRO519) THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES | ANTIBODY STRUCTURE, CRYPTOCOCCUS, PEPTIDE, PHAGE LIBRARY, POLYSACCHARIDE, COMPLEX (ANTIBODY/PEPTIDE)
1tjh:H (GLY162) to (PRO213) CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE | 2F5, ANTIBODY, GP41, HIV-1, NEUTRALIZING, MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1hh6:B (GLY161) to (PRO211) ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE | ANTIBODY/PEPTIDE, POLYSPECIFICITY, CROSSREACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1, IMMUNE SYSTEM
1hhg:A (GLU212) to (TRP274) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhg:D (GLU212) to (TRP274) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
2h2p:E (GLY170) to (PRO220) CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN- | CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT
1hhh:A (GLU212) to (TRP274) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhi:A (GLU212) to (TRP274) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhi:D (GLU212) to (TRP274) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhj:D (GLU212) to (TRP274) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhk:A (GLU212) to (TRP274) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
1hhk:D (GLU212) to (TRP274) THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2 | HISTOCOMPATIBILITY ANTIGEN
2h6p:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING THE HUMAN CYTOCHROME P450 DERIVED PEPTIDE, KPIVVLHGY | IMMUNE SYSTEM, GENE REGULATION
3ixa:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE | TEL1P, TAX, A150P MUTATION, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
4lkx:A (PRO149) to (PRO213) HUMANIZED ANTIBODY 4B12 FAB COMPLEXED WITH A CEMX SEGMENT | IMMUNOGLOBULIN, ANTIBODY, FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM
2hh0:H (PRO192) to (PRO271) STRUCTURE OF AN ANTI-PRP FAB, P-CLONE, IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE. | PRION, PRP, FAB, IMMUNE SYSTEM
1tvb:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2 | MELANOMA; X-RAY; GP100; PEPTIDE; MHC; HLA-A2, IMMUNE SYSTEM
1tvh:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2 | MELANOMA; X-RAY; MODIFIED GP100 PEPTIDE; GP100(209-T2M) PEPTIDE; MHC; HLA-A2, IMMUNE SYSTEM
3vri:A (GLU212) to (TRP274) HLA-B*57:01-RVAQLENVYI IN COMPLEX WITH ABACAVIR | HUMAN LEUKOCYTE ANTIGEN, ANTIGEN PRESENTATION, IMMUNE SYSTEM, T-CELL RECEPTOR
3vrj:A (GLU212) to (TRP274) HLA-B*57:01-LTTKLTNTNI IN COMPLEX WITH ABACAVIR | HUMAN LEUKOCYTE ANTIGEN, ANTIGEN PRESENTATION, IMMUNE SYSTEM, T-CELL RECEPTOR
2hjk:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE | B57, HLA, HIV, IMMUNE SYSTEM
4lnr:A (GLU212) to (TRP274) THE STRUCTURE OF HLA-B*35:01 IN COMPLEX WITH THE PEPTIDE (RPQVPLRPMTY) | HETEROTRIMER, LIGAND FOR T CELL RECEPTOR, IMMUNE SYSTEM
2hn7:A (ASP227) to (TRP274) HLA-A*1101 IN COMPLEX WITH HBV PEPTIDE HOMOLOGUE | PEPTIDE-MHC-COMPLEX, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HUMAN LEUKOCYTE ANTIGEN, HLA, IMMUNOGLOBULIN FAMILY, HEPATITIS B VIRUS, HBV, IMMUNE SYSTEM
1hzh:H (GLU285) to (LYS358) CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM
1i1a:A (GLU209) to (LEU269) CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC | MHC CLASS I FOLD, IG CONSTANT DOMAINS, IMMUNE SYSTEM
1i1a:C (ARG274) to (LYS338) CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC | MHC CLASS I FOLD, IG CONSTANT DOMAINS, IMMUNE SYSTEM
1i1y:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y | HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM
3vxm:A (ASP227) to (TRP274) THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE
3vxp:A (ASP227) to (TRP274) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L) | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE
3vxp:D (GLU212) to (TRP274) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L) | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE
3vxu:A (GLU212) to (TRP274) THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE
3vxu:F (GLU212) to (TRP274) THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE
2hrp:M (ASP143) to (ASN212) ANTIGEN-ANTIBODY COMPLEX | FAB FRAGMENT, CROSS-REACTIVITY, HIV1 PROTEASE, ENZYME INHIBITION, COMPLEX (IMMUNOGLOBULIN/PEPTIDE)
4lsp:H (GLY162) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057 | NEUTRALIZING ANTIBODY VRC-CH31, HIV ENVELOPE GLYCOPROTEIN GP120, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1i4f:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX | MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, MELANOMA-ASSOCIATED ANTIGEN, IMMUNE SYSTEM
2ht2:E (GLY170) to (PRO220) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2ht3:C (GLY170) to (PRO220) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2ht3:E (GLY170) to (PRO220) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
1i7r:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058 | MHC FOLD, IMMUNE SYSTEM
1i7r:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058 | MHC FOLD, IMMUNE SYSTEM
1i7t:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V | MHC FOLD, IMMUNE SYSTEM
1i7t:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V | MHC FOLD, IMMUNE SYSTEM
1i7z:B (PRO151) to (PRO225) ANTIBODY GNC92H2 BOUND TO LIGAND | IGG FOLD, ANTIBODY, CHIMERA, IMMUNE SYSTEM
1il1:A (PRO157) to (PRO220) CRYSTAL STRUCTURE OF G3-519, AN ANTI-HIV MONOCLONAL ANTIBODY | FAB, BETA SHEET STRUCTURE, ANTIBODY, IMMUNE SYSTEM
1im9:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN DOMAIN, ANTIPARALLEL BETA SHEET, ALPHA HELIX, IMMUNE SYSTEM
2i9l:D (GLY168) to (PRO218) STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN | NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX
2i9l:H (GLY168) to (PRO218) STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN | NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX
4m43:H (GLY169) to (PRO227) CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4m7l:L (ALA150) to (ASN216) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT | ANTIBODY, BLOOD CLOTTING-IMMUNE SYSTEM COMPLEX
1uqs:A (VAL216) to (GLY280) THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID | GLYCOPROTEIN, LIPID, GMM, CD1B, MHC, ANTIGEN PRESENTATION
2ig2:L (ALA145) to (PRO210) DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN) | IMMUNOGLOBULIN
3j2x:A (ASN149) to (ASN214) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM
3j2x:B (PRO653) to (PRO716) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM
3j2x:C (ASN1149) to (ASN1214) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM
3j2x:D (PRO1653) to (PRO1716) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM
3j2x:E (ASN2149) to (ASN2214) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM
3j2x:F (PRO2653) to (PRO2716) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM
3j2x:G (ASN3149) to (ASN3214) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM
3j2x:H (PRO3653) to (PRO3716) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM
3j30:A (ASN149) to (ASN214) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM
3j30:B (PRO653) to (PRO716) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM
3j30:C (ASN1149) to (ASN1214) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM
3j30:D (PRO1653) to (PRO1716) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM
3j30:E (ASN2149) to (ASN2214) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM
3j30:F (PRO2653) to (PRO2716) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM
3j30:G (ASN3149) to (ASN3214) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM
3j30:H (PRO3653) to (PRO3716) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152 | ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM
1uxs:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS | IMMUNE SYSTEM/PEPTIDE, COMPLEX (HLA/PEPTIDE), IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2705, EPSTEIN-BARR VIRUS,
2x4o:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128 | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION
2x4o:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128 | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION
2x4p:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE | GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1)
2x4p:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE | GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1)
2x4q:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE | IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION, PHOTOCLEAVABLE PEPTIDE
2x4r:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE | IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM
2x4r:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE | IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM
2x4s:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN | PHOTOCLEAVABLE PEPTIDE, GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1)
2x4s:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN | PHOTOCLEAVABLE PEPTIDE, GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1)
2x4t:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE | MHC CLASS I, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM
2x4t:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE | MHC CLASS I, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM
2x4u:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476 | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION
2ipu:K (ASN144) to (ASN209) PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE | WWDDD, CDR, ABETA, IMMUNE SYSTEM
2ipu:G (PRO149) to (PRO212) PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE | WWDDD, CDR, ABETA, IMMUNE SYSTEM
3wkm:H (GLY172) to (PRO222) THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT | PDZ DOMAIN, HYDROLASE
3wkn:B (PRO271) to (SER337) CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG | IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM
3wkn:M (PRO271) to (LYS338) CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG | IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM
2x70:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE | IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION
3wl9:A (GLU212) to (TRP274) HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8I10F) | HIV-1, NEF, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, TCR, T CELL RECEPTOR
3wlb:A (GLU212) to (TRP274) HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8T10F) | HIV-1, NEF, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, TCR, T CELL RECEPTOR
4mj5:A (ASP227) to (TRP274) HLA-A11 COMPLEXED WITH A PEPITDE | MHC, T CELL RESPONSES, IMMUNE SYSTEM-PEPTIDE COMPLEX
4mj6:A (GLU212) to (TRP274) HLA-A11 COMPLEXED WITH A MUTATED PEPTIDE | MHC, T CELL RESPONSES, IMMUNE SYSTEM-PEPTIDE COMPLEX
5alc:H (PRO149) to (PRO213) TICAGRELOR ANTIDOTE CANDIDATE FAB 72 IN COMPLEX WITH TICAGRELOR | IMMUNE SYSTEM, ANTIBODY FRAGMENT, ANTIDOTE, DRUG
1v7m:I (PRO152) to (VAL214) HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX
3wn5:B (LYS274) to (LYS338) CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA | RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM
5anm:F (ASP473) to (VAL543) CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY | IMMUNE SYSTEM, THERAPEUTIC ANTIBODY, IGG, IGE, ASTHMA
5anm:G (ASP473) to (VAL543) CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY | IMMUNE SYSTEM, THERAPEUTIC ANTIBODY, IGG, IGE, ASTHMA
5any:I (GLY162) to (SER212) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
5any:J (GLY162) to (SER212) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
5any:K (GLY162) to (SER212) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
5any:L (GLY162) to (SER212) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
1jgd:A (GLU212) to (TRP274) HLA-B*2709 BOUND TO DECA-PEPTIDE S10R | MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN), IMMUNE SYSTEM
1jge:A (ILE213) to (TRP274) HLA-B*2705 BOUND TO NONA-PEPTIDE M9 | MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN), IMMUNE SYSTEM
1jht:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART- 1/MELAN-A. | HUMAN, TUMOR IMMUNITY, MELANOMA ANTIGEN, MHC, VACCINATION, MELANOMA, CLASS I, IMMUNE SYSTEM
3ws3:A (ASP236) to (TRP298) CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE | CLASS I MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, INSULIN, H-2D, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, IMMUNE SYSTEM
3ws3:C (ASP236) to (TRP298) CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE | CLASS I MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, INSULIN, H-2D, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, IMMUNE SYSTEM
3ws6:B (ASP236) to (TRP298) CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH A MIMOTOPIC PEPTIDE | CLASS I MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, MIMOTOPE, H-2D, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, IMMUNE SYSTEM
1jn6:A (GLY161) to (SER210) CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES | IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM
1jn6:B (PRO154) to (PRO217) CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES | IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM
1jnh:H (PRO154) to (PRO217) CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES | IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM
1jnl:H (PRO152) to (LYS222) CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES | IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM
1jpt:H (PRO153) to (PRO217) CRYSTAL STRUCTURE OF FAB D3H44 | ANTIGEN-ANTIBODY RECOGNITION, HUMANIZED ANTIBODY, BLOOD COAGULATION, CRYSTAL STRUCTURE, IMMUNE SYSTEM
1vpo:L (ILE149) to (ASP217) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE | FAB FRAGMENT, ANTI-STEROID, TESTOSTERONE COMPLEX, IMMUNE SYSTEM
2j8u:A (GLU212) to (TRP274) LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION. | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, MHC I, MEMBRANE, SECRETED, GLYCATION, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, DISEASE MUTATION, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL
2j8u:H (GLU212) to (TRP274) LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION. | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, MHC I, MEMBRANE, SECRETED, GLYCATION, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, DISEASE MUTATION, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL
5awn:H (PRO149) to (GLU212) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC176 FAB | HIV-1, ENV, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
1w0v:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 | IMMUNE SYSTEM, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA- B*2705, MHC I
1w0w:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 | IMMUNE SYSTEM, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA- B*2705, MHC I
4n0f:A (GLU207) to (LEU267) HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN | ALPHA/BETA, RECEPTOR, IGG CONSTANT DOMAIN, MEMBRANE, IMMUNE SYSTEM
3x11:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*57:01.I80N.L82R.R83G | IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS LILRS, TCRS, KIRS, PLASMA MEMBRANE, IMMUNE SYSTEM
3x12:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*57:01.I80N | IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS, LILR, TCR, KIR, PLASMA MEMBRANE, IMMUNE SYSTEM
3x13:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*0801.N80I | IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS, LILR, TCR, KIR, PLASMA MEMBRANE, IMMUNE SYSTEM
3x14:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*0801.N80I.R82L.G83R | IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS, LILR, TCR, KIR, PLASMA MEMBRANE, IMMUNE SYSTEM
2xpg:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX | IMMUNE SYSTEM, AUTOIMMUNITY, MULTIPLE SCLEROSIS
2jb5:L (ALA148) to (PRO213) FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-1 | CDR, TSC, FAB, HUCAL, FLUORESCENT DYE, IMMUNOGLOBULIN DOMAIN, ANTIBODY FRAGMENT, DIAGNOSTIC IMAGING, IMMUNE SYSTEM
2jcc:A (GLU212) to (TRP274) AH3 RECOGNITION OF MUTANT HLA-A2 W167A | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, RECEPTOR, POLYMORPHISM, PYRROLIDONE CARBOXYLIC ACID, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL, UBL CONJUGATION, IMMUNE RESPONSE, HYPOTHETICAL PROTEIN
2jcc:H (GLU212) to (TRP274) AH3 RECOGNITION OF MUTANT HLA-A2 W167A | GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, RECEPTOR, POLYMORPHISM, PYRROLIDONE CARBOXYLIC ACID, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL, UBL CONJUGATION, IMMUNE RESPONSE, HYPOTHETICAL PROTEIN
5b38:A (GLU212) to (TRP274) KIR3DL1*005 IN COMPLEX WITH HLA-B*57:01 | INNATE IMMUNE RECEPTOR, KIR, NATURAL KILLER CELL, IMMUNE SYSTEM
5b39:A (GLU212) to (TRP274) KIR3DL1*015 IN COMPLEX WITH HLA-B*57:01 | INNATE IMMUNE RECEPTOR, KIR, NATURAL KILLER CELL, IMMUNE SYSTEM
1w72:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3 | IMMUNE SYSTEM, HLA/FAB FRAGMENT, HUMAN LEUCOCYTE ANTIGEN, PEPTIDE-SPECIFIC FAB, TCR-LIKE BINDING, MHC-I
4n8v:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A | ANTIGEN PRESENTATION, CELL LYSING, KIR BINDING, MEMBRANE, KIR2DS2, ACTIVATING KIR, IMMUNE SYSTEM
4n8v:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A | ANTIGEN PRESENTATION, CELL LYSING, KIR BINDING, MEMBRANE, KIR2DS2, ACTIVATING KIR, IMMUNE SYSTEM
5bq7:A (PRO154) to (PRO218) CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT | HUMAN ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM
5bs0:A (ASP227) to (TRP274) MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1 | IMMUNO PMHC TCR TITIN, IMMUNE SYSTEM
4ncc:H (PRO155) to (PRO218) NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS | IMMUNOGLOBIN, ANTIBODY, MURINE NOROVIRUS, IMMUNE SYSTEM
4ncc:2 (PRO155) to (PRO218) NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS | IMMUNOGLOBIN, ANTIBODY, MURINE NOROVIRUS, IMMUNE SYSTEM
1wbx:A (ASP212) to (TRP274) CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE | MHC CLASS I, INFLUENZA PEPTIDE, HA468, IMMUNE SYSTEM
2xzc:H (PRO155) to (PRO219) CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT | IMMUNE SYSTEM
2xzq:H (PRO156) to (PRO219) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF | BETA-SANDWICH IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, SECRETED PROTEIN, IMMUNE SYSTEM
1k8d:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE NON-CLASSICAL MHC CLASS IB QA-2 COMPLEXED WITH A SELF PEPTIDE | CRYSTAL STRUCTURE, NON-CLASSICAL MHC CLASS I, ANTIGEN PRESENTATION, PREIMPLANTATION EMBRYO DEVOLEPMENT GENE PRODUCT, QA-2, Q9, IMMUNE SYSTEM
5bxf:C (GLU207) to (LEU267) APO FCRN STRUCTURE AT PH 4.5 | FCRN, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
1kbg:H (ASP212) to (TRP274) MHC CLASS I H-2KB PRESENTED GLYCOPEPTIDE RGY8-6H-GAL2 | MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, ANTIGEN PRESENTATION, GLYCOPEPTIDE, CELLULAR IMMUNITY, IMMUNOLOGY, CELL SURFACE RECEPTOR, SYNTHETIC PEPTIDE, VACCINE, IMMUNE SYSTEM
1kcr:H (PRO152) to (PRO215) CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE | ANTIBODY, PEPTIDE ANTIGEN COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM
4nj9:L (ASN145) to (ASN210) CRYSTAL STRUCTURE OF FAB 8B10 IN COMPLEX WITH MPTS | IMMUNOGLOBULIN FOLD, MPTS, IMMUNE SYSTEM
5c07:A (GLU212) to (TRP274) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0e:A (ASP227) to (TRP274) HLA-A02 CARRYING YLGGPDFPTI | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0f:A (ASP227) to (TRP274) HLA-A02 CARRYING RQWGPDPAAV | IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM
5c0h:A (ASP227) to (TRP274) HLA-A02 CARRYING MVWGPDPLYV | IMMUNO, HLA-A02, 1E6-TCR, CROSS-RTEACTIVITY, IMMUNE SYSTEM
5c0i:A (ASP227) to (TRP274) HAL-A02 CARRYING RQFGPDFPTI | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0j:A (ASP227) to (TRP274) HLA-A02 CARRYING RQFGPDWIVA | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
1kj2:I (ASP212) to (TRP274) MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX | T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, ALLOGENEIC, IMMUNE SYSTEM
4no0:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1 | NONPHOSPHORYLATED PEPTIDE, PEPTIDE-MHC COMPLEX, MHC, LILRB1, POST TRANSLATIONAL MODIFICATION, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, TUMOR ANTIGEN, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX
3jbq:L (ILE144) to (ASN210) DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR, PDE6 | PHOSPHODIESTERASE, PHOTORECEPTOR, PDE6, HYDROLASE-IMMUNE SYSTEM COMPLEX
3jbq:l (ILE144) to (ASN210) DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR, PDE6 | PHOSPHODIESTERASE, PHOTORECEPTOR, PDE6, HYDROLASE-IMMUNE SYSTEM COMPLEX
1kjv:A (ASP212) to (TRP274) TAP-B-ASSOCIATED RAT MHC CLASS I MOLECULE | PEPTIDE-MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE SYSTEM
2ltq:F (PRO155) to (LYS215) HIGH RESOLUTION STRUCTURE OF DSBB C41S BY JOINT CALCULATION WITH SOLID-STATE NMR AND X-RAY DATA | MEMBRANE PROTEIN, OXIDOREDUCTASE, DISULFIDE BOND, REDOX-ACTIVE CENTER, CELL INNER MEMBRANE, CELL MEMBRANE, CHAPERONE, ELECTRON TRANSPORT, MEMBRANE, TRANSMEMBRANE, TRANSPORT
4nqs:A (PRO271) to (LYS338) KNOB-INTO-HOLE IGG FC | IMMUNOGLOBULIN, IMMUNE SYSTEM
4nqs:B (PRO271) to (LYS338) KNOB-INTO-HOLE IGG FC | IMMUNOGLOBULIN, IMMUNE SYSTEM
4nqs:G (ASP270) to (LYS338) KNOB-INTO-HOLE IGG FC | IMMUNOGLOBULIN, IMMUNE SYSTEM
4nqs:H (ASP270) to (LYS338) KNOB-INTO-HOLE IGG FC | IMMUNOGLOBULIN, IMMUNE SYSTEM
4nqt:A (PRO271) to (SER337) ANTI-PARALLEL FC-HOLE(T366S/L368A/Y407V) HOMODIMER | IMMUNOGLOBULIN, IMMUNE SYSTEM
4nqv:G (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nqx:K (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE | IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4nrz:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6 | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nsk:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND V3P | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-PEPTIDE COMPLEX
1kpr:A (GLU212) to (TRP274) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E | HLA-E, MHC, NON-CLASSICAL MHC, HLA, BETA 2 MICROGLOBULIN, IMMUNE SYSTEM
1kpr:C (GLU212) to (TRP274) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E | HLA-E, MHC, NON-CLASSICAL MHC, HLA, BETA 2 MICROGLOBULIN, IMMUNE SYSTEM
1kpu:A (ASP212) to (TRP274) HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/VSV8 | MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE-MHC, IMMUNE SYSTEM
1x7q:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE | PEPTIDE-MHC-COMPLEX, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HUMAN LEUKOCYTE ANTIGEN, HLA, IMMUNOGLOBULIN FAMILY, SARS, IMMUNE SYSTEM
4nzr:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB | LEUCINE-RICH REPEAT, BROAD ANTIBODY-BINDING, BLOCK ANTIBODY-ANTIGEN UNION, VARIABLE REGION, IMMUNE SYSTEM-PROTEIN BINDING COMPLEX
1xf4:A (ILE144) to (ASN212) STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING | ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, TWINNING, IMMUNE SYSTEM
4o2c:A (GLU212) to (TRP274) AN NT-ACETYLATED PEPTIDE COMPLEXED WITH HLA-B*3901 | IG-LIKE, IMMUNE SYSTEM
4o2e:D (GLU212) to (TRP274) A PEPTIDE COMPLEXED WITH HLA-B*3901 | IG-LIKE, IMMUNE SYSTEM
4o2f:A (GLU212) to (TRP274) A PEPTIDE COMPLEXED WITH HLA-B*3901 | IG-LIKE, IMMUNE SYSTEM
4o58:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/3/1975 (H3N2) INFLUENZA HEMAGGLUTININ | IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cd3:G (PRO148) to (PRO212) STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7 | VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM
5cd3:A (PRO148) to (PRO212) STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7 | VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM
5cd3:E (PRO148) to (PRO212) STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7 | VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM
1xh3:A (GLU212) to (TRP274) CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501 | IMMUNE SYSTEM
3jwd:P (PRO149) to (PRO213) STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY | HIV-1 VIRAL SPIKE, MOLECULAR MOTION, PROTEIN ARCHITECTURE, RECEPTOR- TRIGGERED ENTRY, TYPE 1 FUSION PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, VIRAL PROTEIN
2ypk:A (GLU212) to (TRP274) STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS | IMMUNE SYSTEM, MICROPOLYMORPHISM
2ypl:A (GLU212) to (TRP274) STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, MICROPOLYMORPHISM
4oaw:C (GLU143) to (ASN210) FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
2nw3:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A | MHC, HLA-B*3508, IMMUNE SYSTEM
1lcs:A (ASN9) to (LYS124) RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS | ANTIPARALLEL BETA-SANDWICH GLYCOPROTEIN, VIRAL PROTEIN
1ldp:H (ASP212) to (LEU272) CRYSTAL STRUCTURE OF MURINE MHC CLASS I H-2LD WITH A MIXTURE OF BOUND PEPTIDES | COMPLEX (MHC I/PEPTIDE), MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNOLOGY, CELLULAR IMMUNITY, PEPTIDE ANTIGEN, CELL SURFACE RECEPTOR, ANTIGEN RECEPTOR, ANTIGEN PRESENTATION
2nx5:K (GLU212) to (TRP274) CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A | TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM
1leg:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE | MHC CLASS I MOLECULE WITH BOUND PEPTIDE, IMMUNE SYSTEM
4od1:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.03, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY | FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM
4ods:H (GLU148) to (LYS209) UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S55-3 | CARBOHYDRATE BINDING, IMMUNE SYSTEM
1lk2:A (ASP212) to (TRP274) 1.35A CRYSTAL STRUCTURE OF H-2KB COMPLEXED WITH THE GNYSFYAL PEPTIDE | CLASS I MHC-PEPTIDE COMPLEX, HIGH RESOLUTION, ANISOTROPIC AND TLS REFINEMENT, IMMUNE SYSTEM
4ofp:D (PRO264) to (GLY338) CRYSTAL STRUCTURE OF SYG-2 D3-D4 | IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, SYNAPTOGENESIS, PROTEIN BINDING, N-LINKED GLYCOSYLATION, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN
4ofy:D (PRO264) to (LYS324) CRYSTAL STRUCTURE OF THE COMPLEX OF SYG-1 D1-D2 AND SYG-2 D1-D4 | IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, SYNAPTOGENESIS, PROTEIN BINDING, N-LINKED GLYCOSYLATION, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN
1lo0:H (GLY168) to (PRO218) CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX | CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
1lo2:H (GLY168) to (PRO218) RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY | CATALYTIC ANTIBODY, FAB, RETRO-DIELS-ALDERASE, IMMUNE SYSTEM
1lp9:A (GLU212) to (TRP274) XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 | IMMUNOREGULATORY COMPLEX, CLASS I MHC:TCR CO-CRYSTAL, IMMUNE SYSTEM
1lp9:H (GLU212) to (TRP274) XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 | IMMUNOREGULATORY COMPLEX, CLASS I MHC:TCR CO-CRYSTAL, IMMUNE SYSTEM
1m05:C (GLU212) to (TRP274) HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT | MHC CLASS I, HLA B8, EPSTEIN BARR VIRUS, IMMUNE SYSTEM
4okv:B (ASN150) to (ASN217) CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY | MALARIA VECTOR MOSQUITO, COLLAGEN BINDING PROTEIN, BLOOD CLOTTING
4onh:B (HIS154) to (GLY241) CRYSTAL STRUCTURE OF DN6 TCR | IG FOLD, TCR, ANTIGEN RECOGNITION, MHC LIKE, IMMUNE SYSTEM
1xr9:A (GLU212) to (TRP274) CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 | MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B62, HLA-B*1501, COMPLEX (ANTIGEN-PEPTIDE), IMMUNE SYSTEM-LIGASE COMPLEX
1m6o:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE | MHC I, GLYCOPROTEIN, SIGNAL, IMMUNE SYSTEM
1m7d:B (PRO149) to (GLY212) CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE | FAB-CARBOHYDRATE INTERACTIONS, SHIGELLA O-ANTIGEN, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
2zok:G (ASP212) to (TRP274) CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510 | IMMUNE SYSTEM, IG FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, VIRION, VIRULENCE
4osu:L (THR148) to (ALA210) CRYSTAL STRUCTURE OF HCMV GB-NEUTRALIZING SM5-1 FAB FRAGMENT | IMMUNOGLOBULIN, IMMUNE RESPONSE, HCMV NEUTRALIZATION, HCMV GLYCOPROTEIN B, IMMUNE SYSTEM
2zpk:H (PRO149) to (PRO212) CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE | MOUSE IGG FAB FRAGMENT IN COMPLEX WITH ANTIGEN PEPTIDE, IMMUNE SYSTEM
4otx:L (ASN145) to (ARG211) STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT | ANTIBODY, IMMUNE SYSTEM, LIPOPOLYSACCHARIDE, INTERNAL EPITOPE
1mam:L (ILE144) to (ASN212) CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN | IMMUNOGLOBULIN
5czx:C (GLY168) to (PRO219) CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB | ANTIBODY, NOTCH3, ONCOLOGY, IMMUNE SYSTEM
2zsv:A (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598 | IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED
2zsv:C (ASP212) to (TRP274) CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598 | IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED
2zsw:A (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598 | IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED
2zsw:E (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598 | IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED
2zsw:C (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598 | IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED
2zsw:G (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598 | IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED
3kla:D (GLU212) to (TRP274) CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR | MHC, TUMOUR, IMMUNOLOGY, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1mhc:A (ASP212) to (TRP274) MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION | HISTOCOMPATIBILITY ANTIGEN/PEPTIDE, HISTOCOMPATIBILITY ANTIGEN- PEPTIDE COMPLEX
1mhc:D (ASP212) to (TRP274) MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION | HISTOCOMPATIBILITY ANTIGEN/PEPTIDE, HISTOCOMPATIBILITY ANTIGEN- PEPTIDE COMPLEX
1mim:H (PRO151) to (PRO215) IGG FAB FRAGMENT (CD25-BINDING) | IMMUNOGLOBULIN, C REGION
4aei:J (GLY169) to (VAL218) CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX | IMMUNE SYSTEM-TOXIN COMPLEX, ALPHA-TOXIN, CONFORMATIONAL REARRANGEMENT, COMBINING SITE, EPITOPE, PHARMACOLOGICAL SITE, VENOM, VOLTAGE-ACTIVATED SODIUM CHANNEL
1mjj:B (GLY169) to (PRO227) HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG | CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM
5d2l:A (ILE213) to (TRP274) CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2 | TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM
5d2l:G (GLU212) to (TRP274) CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2 | TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM
5d2n:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX | TCR, NLV, HLA-A2, IMMUNE SYSTEM
1mlc:D (GLY165) to (PRO215) MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME | COMPLEX (ANTIBODY/ANTIGEN)
4p3d:A (PRO154) to (PRO217) MT1-MMP:FAB COMPLEX (FORM II) | IMMUNE SYSTEM
3kpm:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE | HLA B*4402, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM
3kpn:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN | HLA B*4403, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM
3kpo:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE | HLA B*4403, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM
3kpq:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE | HLA B*4405, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM-PEPTIDE COMPLEX
3kpr:F (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE | HLA B*4405, TCRPMHC STRUCTURE, TERNARY COMPLEX, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNE SYSTEM
5d4q:B (PRO271) to (LYS338) CRYSTAL STRUCTURE OF GASDALIE IGG1 FC | ADCC, IGG FC, IMMUNE SYSTEM
5d72:N (GLY142) to (PRO208) CRYSTAL STRUCTURE OF MOR04252, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
4pb0:L (ASP143) to (ARG211) STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB53 | ANTIBODY, IMMUNE SYSTEM
1mwa:I (ASP212) to (TRP274) 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX | IG DOMAIN, ANTIGEN RECOGNITION, COMPLEMENTARITY DETERMINING REGION, IMMUNE SYSTEM
5d9q:L (THR146) to (PRO209) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
5d9q:H (PRO147) to (PRO211) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
5d9q:F (PRO147) to (PRO211) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
3kww:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE 'RESTRICTION TRIAD' MUTANT OF HLA B*3508, BETA-2-MICROGLOBULIN AND EBV PEPTIDE | MHC-PEPTIDE, HLA, DISULFIDE BOND, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1yn6:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A PEPTIDE FROM THE INFLUENZA A ACID POLYMERASE | MHC CLASS 1, H2-DB, INFLUENZA A, PEPTIDE OF ACID POLYMERASE, IMMUNE SYSTEM
1yn7:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A MUTATED PEPTIDE (R7A) OF THE INFLUENZA A ACID POLYMERASE | MHC CLASS 1, H2-DB, INFLUENZA A, PEPTIDE OF ACID POLYMERASE, IMMUNE SYSTEM
5dd1:H (PRO149) to (ILE213) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
3kyn:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-G PRESENTING KGPPAALTL PEPTIDE | HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM
3kyo:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE | HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM
3kyo:C (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE | HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM
5ddh:A (ASP227) to (TRP274) STRUCTURE OF HLA-A2:01 WITH THE 12-MER PEPTIDE F12K | MHC, IMMUNE SYSTEM, PEPTIDE-PROTEIN COMPLEX
1n2r:A (GLU212) to (TRP274) A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF, PEPTIDE REPORTOIRE AND T CELL RECOGNITION. | MHC I, SIGNAL, IMMUNE SYSTEM
5deg:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF B*27:06 BOUND TO THE PVIPR PEPTIDE | IMMUNE SYSTEM-COMPLEX, IMMUNE SYSTEM, MHC MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2706
4pg9:A (ASP212) to (TRP274) MHC CLASS I IN COMPLEX WITH SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAL | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX
4pgc:A (ASP212) to (TRP274) MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(3,5-DIIODOTYROSINE)PAL | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX
4pgc:D (ASP212) to (TRP274) MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(3,5-DIIODOTYROSINE)PAL | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX
4pgd:A (ASP212) to (TRP274) MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAF | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX
4pge:A (ASP212) to (TRP274) MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAW | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX
1n3n:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1n3n:C (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1n3n:E (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1n3n:G (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1n59:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV | MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM
1n59:C (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV | MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM
3l3d:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM
3l3g:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM
3l3i:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F7A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM
3l3j:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM
3l3k:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A/F7A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM
5dja:A (PRO271) to (LYS338) FC HETERODIMER DESIGN 9.1 Y407M + T366I | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
5djy:A (PRO271) to (LYS338) FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
5djz:A (PRO271) to (LYS338) FC HETERODIMER DESIGN 7.8 D399M/Y407A + T366V/K409V | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
5dk0:A (PRO271) to (LYS338) FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
1yy9:C (ALA144) to (ASN210) STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC- C225 | CELL SURFACE RECEPTOR; TYROSINE KINASE; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, IMMUNE SYSTEM-TRANSFERASE COMPLEX
1yym:R (GLY1162) to (PRO1213) CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, F23, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3l7f:A (LYS145) to (ARG211) STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4am0:A (SER153) to (PRO216) STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12 | VIRAL PROTEIN, ANTIBODY, NEUTRALISATION
4am0:E (SER153) to (PRO216) STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12 | VIRAL PROTEIN, ANTIBODY, NEUTRALISATION
4pr5:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-D5 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, STRUCTURAL BIOLOGY, IMMUNE SYSTEM
4pra:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-Q5 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
4pre:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-Q5 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
4prn:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-A4 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
3ld8:B (ILE150) to (LEU215) STRUCTURE OF JMJD6 AND FAB FRAGMENTS | JMJD6, FAB FRAGMENTS, IMMUNE SYSTEM
5dq9:B (ASP143) to (ARG211) STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A | ANTIBODY, FAB, COMPLEX, CARBOHYDRATE, IMMUNE SYSTEM
5dq9:D (ASP143) to (ARG211) STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A | ANTIBODY, FAB, COMPLEX, CARBOHYDRATE, IMMUNE SYSTEM
5dq9:L (ASP143) to (ARG211) STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A | ANTIBODY, FAB, COMPLEX, CARBOHYDRATE, IMMUNE SYSTEM
3alu:A (CYS1) to (LEU51) CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH RAFFINOSE | CEL-IV, C-TYPE LECTIN, RAFFINOSE, SUGAR BINDING PROTEIN
3alu:C (CYS1) to (LEU51) CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH RAFFINOSE | CEL-IV, C-TYPE LECTIN, RAFFINOSE, SUGAR BINDING PROTEIN
4pv8:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF H2KB-Q600F COMPLEX | TCR, T CELL, H2KB, HETEROCLITIC EPITOPES, CD8 T CELL, CORONAVIRUS, IMMUNE SYSTEM
1zhb:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE | MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM
1zhb:D (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE | MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM
1zhb:G (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE | MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM
1zhb:J (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE | MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM
3lkn:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3lko:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3lkp:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1zhk:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY | T-CELL RECEPTOR, BULGED EPITOPES, IMMUNE SYSTEM
1zhl:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY | T-CELL RECEPTOR, BULGED EPITOPES, IMMUNE SYSTEM
3lkr:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
5dur:B (PRO157) to (PRO221) INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY 100F4 | INFLUENZA VIRUS, ANTIBODY, COMPLEX, NEUTRALIZE, IMMUNE SYSTEM
5dvl:A (PRO271) to (LYS338) FC DESIGN 20.8.37 A CHAIN HOMODIMER Y349S/T366M/K370Y/K409V | HEAD-TO-TAIL HOMODIMER, IMMUNOGLOBULIN, FC, IMMUNE SYSTEM
3ln4:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2 | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, PEPTIDE-BINDING MOTIFS, DISULFIDE BOND, IMMUNE SYSTEM
3ln5:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*4104 IN COMPLEX WITH A 11MER SELF-PEPTIDE DERIVED FROM S-METHYL-5-THIOADENOSINE PHOSPHORYLASE | IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, PEPTIDE-BINDING MOTIFS, DISULFIDE BOND, IMMUNE SYSTEM
1zlu:M (PRO151) to (PRO227) FAB 2G12 + MAN5 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
1zlw:H (PRO151) to (PRO227) FAB 2G12 + MAN8 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
3lqa:L (ALA149) to (ALA213) CRYSTAL STRUCTURE OF CLADE C GP120 IN COMPLEX WITH SCD4 AND 21C FAB | COMPLEX, POLY REACTIVITY, IMMUNE SYSTEM
3lrs:B (GLY142) to (ALA207) STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1 | NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM
1zsd:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY | HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX I, B35, B*3501, BULGED PEPTIDE, IMMUNE SYSTEM
5e2v:H (PRO149) to (PRO213) ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE | IMMUNE SYSTEM
1zvs:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX | THE FIRST CLASS MHC, MAMU, TAT-TL8, IMMUNE SYSTEM
3arb:A (PRO217) to (TRP279) TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH | MOUSE NKT TCR, MOUSE CD1D, IMMUNE SYSTEM
3arg:A (PRO217) to (TRP279) TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2) | MOUSE NKT TCR, MOUSE CD1D, IMMUNE SYSTEM
3lv3:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521) | IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA-B*2705, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, SECRETED, CALCIUM CHANNEL, VOLTAGE-GATED CHANNEL
5e8d:H (GLY167) to (PRO217) CRYSTAL STRUCTURE OF HUMAN EPIREGULIN IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY 9E5 | ANTIBODY, IMMUNOGLOBULIN, MONOCLONAL ANTIBODY, EPIDERMAL GROWTH FACTOR, CANCER, IMMUNE SYSTEM
5e8n:G (ASP212) to (TRP274) THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B) | CANCER, NEO-EPITOPE, TAP-DEFICIENCY, TEIPP, MHC-I, SULFUR-PI INTERACTIONS, NON-CLASSICAL PEPTIDE BINDING, IMMUNE SYSTEM
5e9d:A (GLU212) to (TRP274) RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2 | SINGLE CHAIN TCR-PMHC COMPLEX, PROTEIN BINDING
5e9d:F (GLU212) to (TRP274) RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2 | SINGLE CHAIN TCR-PMHC COMPLEX, PROTEIN BINDING
3m1b:E (GLU207) to (LEU267) CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR | IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-IMMUNE SYSTEM INHIBITOR, IMMUNE SYSTEM- INHIBITOR COMPLEX
4qex:H (PRO148) to (LYS208) CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217 | DUFFY BINDING LIKE (DBL) DOMAIN, IMMUNOGLOBULIN DOMAIN, INVASION, ADHESION, IMMUNITY, PFEBA-175, ANTIBODY, CELL SURFACE, EXTRECELLULAR, CELL ADHESION, RECEPTOR, LIGAND, IMMUNE SYSTEM
4qex:I (PRO148) to (LYS208) CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217 | DUFFY BINDING LIKE (DBL) DOMAIN, IMMUNOGLOBULIN DOMAIN, INVASION, ADHESION, IMMUNITY, PFEBA-175, ANTIBODY, CELL SURFACE, EXTRECELLULAR, CELL ADHESION, RECEPTOR, LIGAND, IMMUNE SYSTEM
4qf1:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF UNLIGANDED CH59UA, THE INFERRED UNMUTATED ANCESTOR OF THE RV144 ANTI-HIV ANTIBODY LINEAGE PRODUCING CH59 | ANTI-HIV ANTIBODY, GP120, IMMUNE SYSTEM
4qhk:M (PRO149) to (PRO213) UCA (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
4qhk:O (PRO149) to (PRO213) UCA (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
4qhk:K (PRO149) to (PRO213) UCA (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
2a83:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420) | IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX),HLA-B*2705
3b3i:A (GLU212) to (TRP274) CITRULLINATION-DEPENDENT DIFFERENTIAL PRESENTATION OF A SELF-PEPTIDE BY HLA-B27 SUBTYPES | HLA-B2709, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, G-PROTEIN COUPLED RECEPTOR, PHOSPHORYLATION, RECEPTOR, TRANSDUCER, PROTEIN BINDING, IMMUNE SYSTEM
3ma7:C (PRO217) to (TRP279) CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D | GAMMA DELTA T CELLS, GLYCOLIPID PRESENTATION, MHC, CD1, CELL MEMBRANE, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, SECRETED, IMMUNE SYSTEM, DISULFIDE BOND, IMMUNITY
3ma7:A (PRO217) to (TRP279) CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D | GAMMA DELTA T CELLS, GLYCOLIPID PRESENTATION, MHC, CD1, CELL MEMBRANE, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, SECRETED, IMMUNE SYSTEM, DISULFIDE BOND, IMMUNITY
4ba8:A (GLU35) to (LYS102) HIGH RESOLUTION NMR STRUCTURE OF THE C MU3 DOMAIN FROM IGM | IMMUNE SYSTEM, IMMUNOGLOBULIN CONSTANT REGION
2adg:B (GLY162) to (PRO212) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 | ANTI-CD4, INTERFACIAL METAL, ANTIBODY RECOGNITION, IMMUNE SYSTEM
3mcl:H (GLY168) to (PRO219) ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3b6s:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) | IMMUNE SISTEM/COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA-B*2705, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
4qok:A (GLU212) to (ARG273) STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM
3mgo:G (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
3mgt:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
3mgt:G (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 | BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM
3mj9:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10 | IMMUNOGLOBULIN TANDEM DOMAIN, RECEPTOR-ANTIBODY COMPLEX, CELL ADHESION, CELL JUNCTION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, COSTIMULATION, HAMSTER IGG, TRANSMEMBRANE, IMMUNE SYSTEM
5enw:A (ASP227) to (TRP274) STRUCTURE OF HLA-A2:01 WITH PEPTIDE G9L | PEPTIDE COMPLEX, MHC, IMMUNE SYSTEM
5eo0:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B0702-RFL9 | TCR, T CELL, HLA B*0702, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM
5eo1:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B0702-RL9 | TCR, T CELL, HLA B*0702, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM
3mlw:M (THR145) to (PRO208) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
4qrq:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL | HLA B*0801, HUAMN HEPATITIS C VIRUS, TCR, T CELL, IMMUNE SYSTEM
4qrs:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELK_IYM, ELKRKMIYM | HLA B*0801, CMV, TCR, T CELL, IMMUNE SYSTEM
4qrt:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELN_YYM, ELNRKMIYM | HLA B*0801, CMV, TCR, T CELL, IMMUNE SYSTEM
4qru:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELR_MYM, ELRRKMMYM | HLA B*0801, CMV, TCR, T CELL, IMMUNE SYSTEM
3mod:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED IGG) WITH 11 AA GP41 MPER-DERIVED PEPTIDE | HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3bgf:H (GLY164) to (PRO214) X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB | ANTIGEN-ANTIBODY COMPLEX, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, VIRULENCE, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
3bgf:B (GLY164) to (PRO214) X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB | ANTIGEN-ANTIBODY COMPLEX, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, VIRULENCE, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
5esz:H (PRO149) to (LYS210) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244 | HIV-1, ENV, V1V2, CH0219, CHAVI, IMMUNE SYSTEM
5eu4:A (ASP227) to (TRP274) HLA CLASS I ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5eu4:D (ASP227) to (TRP274) HLA CLASS I ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5eu5:A (ASP227) to (TRP274) HLA CLASS I ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
3mrb:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE A7H VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, CYTOMEGALOVIRUS, PP65 PROTEIN
3mrd:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, CYTOMEGALOVIRUS, PP65 PROTEIN
3mrf:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, EPSTEIN-BARR VIRUS, BMLF1 PROTEIN, EB2 PROTEIN
3mrh:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE N3S VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mri:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mrk:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH AFP137 NONAPEPTIDE | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, TUMORAL PEPTIDE, ALPHA-FETOPROTEIN
3mrr:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, PROSTAGLANDIN TRANSPORTER, TUMORAL PEPTIDE, MELAN-A ANALOGUE, MART1 ANALOGUE, SELF PEPTIDE
3bn9:F (PRO149) to (PRO213) CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2 | ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME- INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, SERINE PROTEASE, SIGNAL- ANCHOR, TRANSMEMBRANE
3bo8:A (GLU212) to (TRP274) THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-A1 COMPLEXED WITH THE MAGE-A1 PEPTIDE | MELANOMA ASSOCIATED ANTIGEN, MAGE, MAGE-A1, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-A1, HLA-A010101, TCR, T-CELL RECEPTOR, ANTIBODY, FAB-HYB3, HYB3, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MEMBRANE, MHC I, SULFATION, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, SECRETED, TUMOR ANTIGEN, IMMUNE SYSTEM
3bp4:A (GLU212) to (TRP274) THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2705 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, BETA-2-MICROGLOBULIN, B2M, CATHEPSIN A, PCATA, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CARBOXYPEPTIDASE, HYDROLASE, LYSOSOME, PROTEASE, ZYMOGEN, IMMUNE SYSTEM
3bp7:A (GLU212) to (TRP274) THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2709 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-B*2709, HLA-B2709, BETA-2-MICROGLOBULIN, B2M, CATHEPSIN A SIGNAL SEQUENCE, PCATA, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CARBOXYPEPTIDASE, HYDROLASE, LYSOSOME, PROTEASE, ZYMOGEN, IMMUNE SYSTEM
5f1n:A (GLU213) to (TRP275) MHC COMLEXED TO 11MER PEPTIDE | MHC, IMMUNE SYSTEM
5f3h:C (PRO152) to (PRO216) STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5f3h:E (PRO152) to (PRO216) STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5f3h:G (PRO152) to (PRO216) STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5f6j:F (GLY146) to (PRO212) CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE | FAB FRAGMENT, HIV-1, ANTIBODY, VIRAL PROTEIN-IMMUE SYSTEM COMPLEX
3myj:D (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT. | WT-1 PEPTIDE, R1Y MUTATION, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3bvn:D (GLU212) to (ARG273) HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-B14, HLA-B*14, HLA-B1402, HLA-B*1402, PLMP2, ANKYLOSING SPONDYLITIS, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ALTERNATIVE SPLICING, CYTOPLASM, HOST-VIRUS INTERACTION, MEMBRANE, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM
3bw9:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12- MER PEPTIDE FROM THE PP65 PROTEIN | HLA B*3508, CRYSTAL STRUCTURE, HCMV, PP65, IMMUNOLOGY, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, TEGUMENT PROTEIN, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
4bsw:A (ASP376) to (LEU443) HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 | IMMUNE SYSTEM, BISPECIFIC, SCAFFOLD, ANTIBODY ENGINEERING, FC DOMAIN, IGG, IGG1, IMMUNOGLOBULIN G, ZYMEWORKS INC.
3bxn:A (GLU212) to (TRP274) THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 COMPLEXED WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEOKOCYTE ANTIGEN, HLA, HLA-B14, HLA-B*1402, HLA-B1402, HLA-B*14, PCATA, CATHEPSIN A, ANKYLOSING SPONDYLITIS, AUTOIMMUNITY, IMMUNE SYSTEM
4r4f:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF NON-NEUTRALIZING, A32-LIKE ANTIBODY 2.2C IN COMPLEX WITH HIV-1 YU2 GP120 | HIV-1 ATTACHMENT PROTEIN, MEMBRANE, VIRAL PROTEIN-IMMUNE SYSTEM- INHIBITOR COMPLEX
4r7d:A (PRO154) to (PRO218) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7d:C (PRO154) to (PRO218) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7d:I (PRO154) to (ARG215) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
3c8k:A (ASP212) to (TRP274) THE CRYSTAL STRUCTURE OF LY49C BOUND TO H-2KB | NATURAL KILLER CELL RECEPTOR; MHC; VIRUS; CRYSTAL STRUCTURE, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM
4r7n:I (GLY167) to (PRO218) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
3c9n:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A SARS CORONA VIRUS DERIVED PEPTIDE BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501 | MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HLA-B*1501, SARS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3ncy:Q (PRO156) to (VAL218) X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT | MEMBRANE PROTEIN COMPLEX WITH FAB FRAGMENT, ARGININE AGMATINE ANTIPORTER, VIRTUAL PROTON PUMP, APC SUPERFAMILY, IMMUNE SYSTEM, TRANSPORT PROTEIN
3cfb:H (SER151) to (LYS222) HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K | IMMUNOGLOBULIN, BLUE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM, ELECTRON TRANSFER
3cfb:B (SER151) to (LYS222) HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K | IMMUNOGLOBULIN, BLUE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM, ELECTRON TRANSFER
3nfp:A (PRO152) to (PRO216) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, DACLIZUMAB, ZENAPAX, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM, IMMUNE SYSTEM-CYTOKINE COMPLEX
3nfn:A (GLU212) to (TRP274) RECOGNITION OF PEPTIDE-MHC BY A V-DELTA/V-BETA TCR | IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM
3ngb:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4c55:B (ASP376) to (LEU443) CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC | IMMUNE SYSTEM, IGG, ANTIBODY, IMMUNOGLOBULIN, IGG1
4ris:H (PRO149) to (PRO213) STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK | ANTIBODY, IGG FOLD, IMMUNE SYSTEM, HIV-1 GP120 V2 REGION
3nps:B (GLY162) to (PRO213) CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4 | HYDROLASE, ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME-INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, MEMBRANE, SERINE PROTEASE, SIGNAL-ANCHOR, TRANSMEMBRANE, HYDROLASE - IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
4cdh:B (ASP157) to (LEU224) CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC-FRAGMENT | IMMUNE SYSTEM, C-LECTIN CRD, SIGN-R1, INMUNE SYSTEM, CAPSULAR POLYSACCHARIDE
4rqq:B (PRO154) to (PRO218) CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | IGG, ANTI-HIV-1 ANTIBODY, HIV-1 ENV TRIMER, IMMUNE SYSTEM
3csy:D (ALA144) to (ARG211) CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR | GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3nwm:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A SINGLE CHAIN CONSTRUCT COMPOSED OF MHC CLASS I H-2KD, BETA-2MICROGLOBULIN AND A PEPTIDE WHICH IS AN AUTOANTIGEN FOR TYPE 1 DIABETES | MHC CLASS I, H-2KD, PEPTIDE-MHC COMPLEX, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3o4o:B (ASP255) to (LYS326) CRYSTAL STRUCTURE OF AN INTERLEUKIN-1 RECEPTOR COMPLEX | CYTOKINE-RECEPTOR COMPLEX, BETA-TREFOIL, IG-LIKE FOLD, IMMUNE SYSTEM
3d0l:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 | HIV, ANTIBODY, NEUTRALIZATION, EPITOPE, 2F5, GP41, IMMUNE SYSTEM
3d18:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH A VARIANT OF THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2(L)) OF EPSTEIN-BARR VIRUS | IMMUNE SYSTEM-COMPLEX, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, IMMUNE SYSTEM
3d25:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF HA-1 MINOR HISTOCOMPATIBILITY ANTIGEN BOUND TO HUMAN CLASS I MHC HLA-A2 | MHC, HLA-A2, SECONDARY ANCHOR RESIDUE, GLYCOPROTEIN, IMMUNE SYSTEM, MINOR HISTOCOMPATIBILITY ANTIGEN, STEM CELL TRANSPLANTATION, IMMUNE RESPONSE
3d3v:A (GLU212) to (TRP274) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(3,4-DIFLUOROPHENYLALANINE)) PEPTIDE | HTLV-1 TAX PEPTIDE, 3, 4-DIFLUOROPHENYLALANINE, MHC CLASS I, HLA-A2, T-CELL RECEPTOR A6, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM
4s2s:H (GLY168) to (PRO218) CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13 | IMMUNOGLOBULIN, IMMUNE SYSTEM
3o9w:A (PRO217) to (TRP279) RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3d6g:B (ASP376) to (LEU443) FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND. | FC FRAGMENT, IGG1, GLYCOSILATED PROTEIN, PROTEIN A MIMETIC PEPTIDE DENDRIMER LIGAND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM
4cw1:A (ASP223) to (TRP270) COMPLEX OF A B14 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE | IMMUNE SYSTEM, MHC, B14
4tnv:H (PRO158) to (LYS218) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnv:J (PRO158) to (PRO221) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnw:J (PRO158) to (ARG222) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
3of6:C (HIS157) to (TRP243) HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE | IG FOLD, IMMUNE SYSTEM
3dif:C (ILE144) to (ASN210) CRYSTAL STRUCTURE OF FABOX117 | ANTIBODY FRAGMENTS, FABS, TRANSIENT EXPRESSION, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4d2n:A (ASP270) to (LYS338) CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC | IMMUNE SYSTEM, IGG, IMMUNOGLOBULIN, IGG1
4tvp:E (THR145) to (PRO208) CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 | HIV-1 ENVELOPE TRIMER, GP120, GP41, MEMBRANE FUSION, VIRAL ENTRY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, TYPE-1 MEMBRANE FUSION GLYCOPROTEIN
3dnk:A (ASP376) to (SER442) ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3do3:B (GLU272) to (LYS338) HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE | IMMUNOGLOBULIN FOLD, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM
3drq:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 SOAKED IN PEG/2- PROPANOL SOLUTION | HIV-1, 2F5, GP41, NMAB, IMMUNE SYSTEM
4u1g:B (GLY171) to (PRO221) PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1 | MALARIA ERYTHROCYTE INVASION ANTIBODY-MEDIATED INHIBITION, IMMUNE SYSTEM
4u1h:A (GLU212) to (TRP274) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1j:A (GLU212) to (ARG273) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1k:A (GLU212) to (TRP274) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1m:A (GLU212) to (ARG273) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1n:A (GLU212) to (TRP274) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
4u1s:A (ASP227) to (TRP274) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
5h94:A (GLU213) to (TRP275) CRYSTAL STRUCTURE OF SWINE MHC CLASSI FOR 1.48 ANGSTROMS | SWINE; CRYSTAL STRUCTURE; MHC I; INFLUENZA A VIRUS; MECHANISM; CTL IMMUNITY, IMMUNE SYSTEM
3dtx:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) | IMMUNE SYSTEM-COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX) I, HLA- B*2705, GLYCOPROTEIN, HOST-VIRUS, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, SECRETED, MHC I, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM
3dx6:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF B*4402 PRESENTING A 10MER EBV EPITOPE | MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM
3dx8:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF B*4405 PRESENTING A 10MER EBV EPITOPE | MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM
3dxa:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN | MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM
3dxa:F (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN | MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM
3dxa:K (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN | MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM
3ox8:D (ASP227) to (TRP274) CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27 | PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM
3oxs:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF HLA A*02:07 BOUND TO HBV CORE 18-27 | PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM
5hga:A (GLU212) to (TRP274) HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hga:D (GLU212) to (TRP274) HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hgb:D (GLU212) to (TRP274) HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hgb:G (GLU212) to (TRP274) HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hgb:J (GLU212) to (TRP274) HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hgd:A (GLU212) to (TRP274) HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hgd:D (GLU212) to (TRP274) HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hgh:A (GLU212) to (TRP274) HLA*A2402 COMPLEXED WITH HIV NEF138 10MER EPITOPE | HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM
5hho:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-G4E | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
4u6g:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH A HYDROCARBON-STAPLED HIV-1 GP41 MPER PEPTIDE | 10E8 ANTIBODY, HIV-1, HYDROCARBON-STAPLE, GP41 MPER, IMMUNE SYSTEM
4u6h:A (GLY168) to (PRO218) VACCINIA L1/M12B9-FAB COMPLEX | IGG2A, FAB, HEAVY CHAIN LIGHT CHAIN
4u6x:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH ALQDA, A 15 MER SELF- PEPTIDE | HLA A*0201, LIGANDOME, TCR, T CELL, IMMUNE SYSTEM
4u6y:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH FLNDK, A 15 MER SELF- PEPTIDE | HLA A*0201, LIGANDOME, TCR, T CELL, IMMUNE SYSTEM
3p30:L (GLY158) to (PRO208) CRYSTAL STRUCTURE OF THE CLUSTER II FAB 1281 IN COMPLEX WITH HIV-1 GP41 ECTODOMAIN | HIV, GP41, CLUSTER 2, FAB, 6-HELIX BUNDLE, IMMUNE SYSTEM
3p4m:A (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-LCMV EPITOPE YTVKYPNL, AN 8-MER PEPTIDE FROM THE LCMV | H2-KB, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM
3p4o:D (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE MUTANT NP205-LCMV-V3A EPITOPE YTAKYPNL, AN 8-MER MODIFIED PEPTIDE FROM THE LCMV | H2-KB, LCMV-V3A, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM
3p9m:D (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-G4 | H2KB, OVA, APL, ALTERED PEPTIDE LIGANDS, OVALBUMIN, TCR, T CELL, IMMUNE SYSTEM
5i15:L (GLU143) to (ARG211) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4dvb:A (GLY161) to (VAL211) THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112 | IMMUNE SYSTEM, HYDROLASE
5i5k:L (LYS145) to (GLY212) STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB | COMPLEMENT, FAB, IMMUNE SYSTEM
4uok:A (GLY383) to (PRO434) ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 3B4C-4 | IMMUNE SYSTEM, VIRAL PROTEIN, ALPHAVIRUS, VENEZUELAN, ANTIBODY NEUTRALIZATION, FAB
3pnw:H (PRO165) to (PRO229) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
5i6x:B (SER174) to (PRO237) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE | MEMBRANE PROTEIN
5i6z:B (SER187) to (PRO237) X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER | MEMBRANE PROTEIN
5i71:B (SER174) to (PRO237) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE | MEMBRANE PROTEIN
5i73:B (SER187) to (PRO237) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES | MEMBRANE PROTEIN
5i75:B (SER174) to (PRO237) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE | MEMBRANE PROTEIN
5i8h:I (PRO147) to (PRO211) CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
4uq2:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE | AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE, IMMUNE SYSTEM
4uq2:C (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE | AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE, IMMUNE SYSTEM
4uq3:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE | IMMUNE SYSTEM, AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE
3pp3:I (PRO155) to (PRO219) EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES | ANTIBODY FAB-FRAGMENT IG-DOMAIN, ANTIBODY, CD20, IMMUNE SYSTEM
3pp4:H (GLY168) to (PRO219) EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES | ANTIBODY FAB FRAGMENT IG-DOMAIN, CD20, CYCLIC PEPTIDE, ANTIBODY ANTIGEN, IMMUNE SYSTEM
5icx:D (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
4e5x:A (ILE213) to (TRP274) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 2 E3- 19K PROTEIN AND MHC CLASS I MOLECULE HLA-A2/TAX | AD2 E3-19K-HLA-A2 COMPLEX, UNIQUE TERTIARY STRUCTURE, ADENOVIRUS E3- 19K, IMMUNE EVASION FUNCTION, MHC CLASS I MOLECULE, ENDOPLASMIC RETICULUM, IMMUNE SYSTEM-TRANSCRIPTION COMPLEX
3pqy:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224 | H2DB, INFLUENZA, TCR, T CELL, PA EPITOPE, REPERTOIRE, VIRAL IMMUNITY, CHIMERIC TCR, IMMUNE SYSTEM
3pqy:F (ASP212) to (TRP274) CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224 | H2DB, INFLUENZA, TCR, T CELL, PA EPITOPE, REPERTOIRE, VIRAL IMMUNITY, CHIMERIC TCR, IMMUNE SYSTEM
5im7:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION | HLA, HIV, QW9, IMMUNE SYSTEM
5im7:C (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION | HLA, HIV, QW9, IMMUNE SYSTEM
3pwj:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT | HUD ANTIGEN, TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING
3pwj:D (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT | HUD ANTIGEN, TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING
3pwl:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE | TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING
3pwl:D (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE | TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING
3pwn:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT | TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, G2L MUTATION, PROTEIN BINDING
3pwp:A (GLU212) to (TRP274) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE | TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING
3pwu:A (GLU211) to (TRP273) AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801(BOLA-A11) | MHC BOLA CONFORMATION, IMMUNODOMINANT EPITOPE CATTLE, IMMUNE SYSTEM
5inc:C (GLU212) to (ARG273) CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION | HLA, HIV, QW9_S3T, IMMUNE SYSTEM
5iop:D (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
4elm:A (PRO217) to (TRP279) CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4ers:H (PRO378) to (PRO442) A MOLECULAR BASIS FOR NEGATIVE REGULATION OF THE GLUCAGON RECEPTOR | GLUCAGON RECEPTOR, CLASS-B GPCR, FAB, GLYCOSYLATION, EXTRA-CELLULAR, IMMUNE SYSTEM
4etq:A (GLY169) to (PRO219) VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5 | VARIABLE DOMAIN, CONSTANT DOMAIN, IGG2A, IGG DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, BETA SHEET, CARBONIC ANHYDRASE FOLD, LOOSE KNOT, CHONDROITIN-SULFATE BINDING SITE, DELTA 262, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4evn:B (GLY163) to (PRO213) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:D (GLY163) to (PRO213) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:F (GLY163) to (PRO213) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:H (GLY163) to (PRO213) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:L (GLY163) to (PRO213) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:N (GLY163) to (PRO213) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
4evn:P (GLY163) to (PRO213) CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN) | ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA
3qdj:A (GLU212) to (TRP274) THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE | MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM
4ezm:A (ASP473) to (VAL543) CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23 | IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM
4ezm:B (ASP473) to (VAL543) CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23 | IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM
3qeh:A (PRO149) to (GLU212) CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY | ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM
3qfd:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE | MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, MELANOMA, IMMUNE SYSTEM
3qfj:A (GLU212) to (TRP274) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE | TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, Y5F MUTATION, IMMUNE SYSTEM
3qi9:A (PRO217) to (TRP279) CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR | AUTOREACTIVITY, T-CELL SURFACE, IMMUNE SYSTEM
5j6h:A (ASP212) to (TRP274) RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C | IMMUNE SYSTEM
4f7p:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009H1N1 PB1 (496-505) | HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS ALLELE RECOGNITION, IMMUNE SYSTEM
4f7t:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505) | HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS-ALLELE RECOGNITION, IMMUNE SYSTEM
4f7t:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505) | HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS-ALLELE RECOGNITION, IMMUNE SYSTEM
3qq3:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES | SWINE MHC CLASS 1, SLA-1*0401, EPITOPE OF INFLUENZA VIRUS, IMMUNE SYSTEM
3qq3:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES | SWINE MHC CLASS 1, SLA-1*0401, EPITOPE OF INFLUENZA VIRUS, IMMUNE SYSTEM
3qum:B (GLY163) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY | KALLIKREIN FOLD, PROSTATE-SPECIFIC ANTIGEN, SERINE PROTEASE, NEGATIVE REGULATION OF ANGIOGENESIS, NATURAL POST-TRANSDUCTIONAL MODIFICATION, N-LINKED AND O-LINKED GLYCOSYLATION, IMMUNE SYSTEM
3qux:A (PRO217) to (TRP279) STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4w4n:A (ILE377) to (LEU443) CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A | HUMAN FC ASYMMETRY DYNAMICS IMMUNE MOLECULE, IMMUNE SYSTEM
3qzw:A (GLU212) to (TRP274) PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402 | IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM, CORECEPTOR
3qzw:D (GLU212) to (TRP274) PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402 | IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM, CORECEPTOR
3r08:L (ASP143) to (ARG211) CRYSTAL STRUCTURE OF MOUSE CD3EPSILON IN COMPLEX WITH ANTIBODY 2C11 FAB | CD3EPSILON, ANTIBODY, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM
4fmk:A (ARG184) to (ARG249) CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2 | IMMUNOGLOBULIN-LIKE DOMAIN, IG DOMAIN, VIRAL ENTRY RECEPTOR, CELL ADHESION
4fnl:L (ALA144) to (ASN210) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM
3raj:H (GLY169) to (LYS216) CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7 | CD38, ADP-RIBOSYL CYCLASE, CYCLIC ADP-RIBOSE, X-CRYSTALLOGRAPHY, CALCIUM SIGNALING, AGONISTIC ANTIBODY, HB7, HYDROLASE-IMMUNE SYSTEM COMPLEX
4fp8:O (ALA144) to (ASN210) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3rew:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | MHC CLASS I, TUMOUR ANTIGEN TARGETING, IMMUNE SYSTEM, HLA-A2, EPSTEIN BARR VIRUS, ALLOREACTIVITY, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, IMMUNOGLOBULIN DOMAIN
3rew:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | MHC CLASS I, TUMOUR ANTIGEN TARGETING, IMMUNE SYSTEM, HLA-A2, EPSTEIN BARR VIRUS, ALLOREACTIVITY, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, IMMUNOGLOBULIN DOMAIN
4fqh:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF FAB CR9114 | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPE, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, INFLUENZA VIRUS, INFLUENZA VACCINES, MEMBRANE FUSION, IMMUNE SYSTEM
4fqh:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF FAB CR9114 | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPE, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, INFLUENZA VIRUS, INFLUENZA VACCINES, MEMBRANE FUSION, IMMUNE SYSTEM
4fqr:d (GLU143) to (ARG211) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqr:h (GLU143) to (ASN210) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqr:r (GLU143) to (ASN210) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqr:t (GLU143) to (ASN210) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqr:v (GLU143) to (ASN210) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqr:x (LYS145) to (ASN210) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqv:I (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqv:N (GLY142) to (PRO208) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqy:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3rgv:C (ASP212) to (TRP274) A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS | TCR, MHC, MHC CLASS I, IMMUNE SYSTEM
5jny:A (PRO149) to (PRO213) CRYSTAL STRUCTURE OF 10E8 FAB | MPER, HIV, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
4ftv:A (GLU212) to (TRP274) THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE | TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, HIGH AFFINITY, C134, IMMUNE SYSTEM
3ri5:H (PRO158) to (LYS218) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND PICROTOXIN | MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4g43:A (PRO208) to (SER269) STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO P5E | MHC I COMPLEX, NARROW BINDING GROOVE, IMMUNE SYSTEM
4g9d:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B2705-KK10 | TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM
4g9f:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M | TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM
5k9q:S (PRO164) to (PRO228) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
4gay:B (ILE144) to (ASN212) STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 | ANTIBODY FAB, NEUTRALIZING ANTIBODY, HCV E2, IMMUNE SYSTEM
4gkn:A (GLU212) to (TRP274) A2-MHC COMPLEX CARRYING FATGIGIITV | MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM
4gkn:D (GLU212) to (TRP274) A2-MHC COMPLEX CARRYING FATGIGIITV | MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM
4gko:B (THR369) to (PRO439) CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23 | IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM
4gko:D (ASP473) to (VAL541) CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23 | IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM
4gko:F (LYS367) to (PRO439) CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23 | IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM
4gks:A (GLU212) to (TRP274) A2-MHC COMPLEX CARRYING FLTGIGIITV | MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM
4grg:C (THR369) to (THR434) CRYSTAL STRUCTURE OF IGE COMPLEXED WITH E2_79, AN ANTI-IGE INHIBITOR | IG-FOLD, IMMUNITY, HIGH/LOW AFFINITY RECEPTOR, IMMUNE SYSTEM- INHIBITOR COMPLEX
4grg:C (ASP473) to (VAL543) CRYSTAL STRUCTURE OF IGE COMPLEXED WITH E2_79, AN ANTI-IGE INHIBITOR | IG-FOLD, IMMUNITY, HIGH/LOW AFFINITY RECEPTOR, IMMUNE SYSTEM- INHIBITOR COMPLEX
4grg:D (ASP473) to (VAL543) CRYSTAL STRUCTURE OF IGE COMPLEXED WITH E2_79, AN ANTI-IGE INHIBITOR | IG-FOLD, IMMUNITY, HIGH/LOW AFFINITY RECEPTOR, IMMUNE SYSTEM- INHIBITOR COMPLEX
5swq:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH NA231, AN INFLUENZA EPITOPE | HLA-A*02:01, CROSS-REACTIVITY, HETEROLOGOUS IMMUNITY, TCR, T CELL, IMMUNE SYSTEM
5swz:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX | H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM
5swz:F (ASP212) to (ARG273) CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX | H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM
5swz:K (ASP212) to (TRP274) CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX | H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM
5t3s:D (PRO149) to (PRO213) HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022 | HIV-1 NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
5t3x:L (ALA144) to (PRO209) 3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074. | HIV, N-LINKED GLYCOSYLATION, BROADLY NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5t3z:L (ALA144) to (ALA208) 3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074 | HIV, N-LINKED GLYCOSYLATION, BROADLY NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
8fab:B (PRO157) to (PRO221) CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
1a1m:A (GLU212) to (TRP274) MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2 | MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B53, HIV, COMPLEX (ANTIGEN/PEPTIDE)
2ak4:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
2ak4:F (GLU212) to (TRP274) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
2ak4:K (GLU212) to (TRP274) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
2ak4:Q (GLU212) to (TRP274) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
4gw1:D (PRO155) to (PRO219) CQFD MEDITOPE | IGG, IMMUNE SYSTEM, EGFR
3roo:C (ASP212) to (TRP274) MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH IMMUNODOMINANT LCMV-DERIVED GP34-41 PEPTIDE | T-CELL RECEPTOR, MHC, GP34, NY-GP34, EPITOPE, POST-TRANSLATIONAL MODIFICATION, LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM, T CELL RECOGNITION, AUTOIMMUNITY, T CELL RECEPTOR, CELL SURFACE
2ol3:H (ASP212) to (TRP274) CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE | T CELL RECEPTOR, CLASS I MHC, H-2KBM8, TCR-PMHC COMPLEX, IMMUNE SYSTEM
1agc:A (GLU212) to (TRP274) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION) | HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
1agf:A (GLU212) to (TRP274) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION) | HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX
2axg:A (GLU212) to (TRP274) THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION | IMMUNE RESPONSE, PMHC, IMMUNE SYSTEM/GENE REGULATION COMPLEX
2bck:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE | IMMUNOGLOBULIN DOMAINS, BETA BARRELS, MHC FOLD, IMMUNE SYSTEM
2bck:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE | IMMUNOGLOBULIN DOMAINS, BETA BARRELS, MHC FOLD, IMMUNE SYSTEM
4hdi:A (ASP148) to (ASN215) CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS | IGG, FAB, IMMUNE SYSTEM
4hdi:B (PRO156) to (ARG216) CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS | IGG, FAB, IMMUNE SYSTEM
2bnr:A (GLU212) to (TRP274) STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES | IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR, SUPERAGONIST PEPTIDE T-CELL VACCINES
4huv:D (ASP212) to (TRP274) CRYSTAL STRUCTURE OF H2DB-NPM6W | VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM
2bvq:A (GLU212) to (TRP274) STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION | GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP HIV-1, GLYCOPROTEIN/PEPTIDE COMPLEX, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE
1of2:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) | IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN)
3sdd:A (PRO217) to (TRP279) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE | CD1D, AUTOIMMUNITY, SELF-RECOGNITION, NKT, IMMUNE SYSTEM
4xh2:E (PRO149) to (PRO213) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4i48:A (ASP227) to (TRP274) STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV ENV DERIVED PEPTIDE | MONOMER, PEPTIDE PRESENTATION, IMMUNE SYSTEM
3skm:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE HLA-B8FLRGRAYVL, MUTANT G8V OF THE FLR PEPTIDE | T CELL RECEPTOR, IMMUNE SYSTEM
1cic:D (PRO152) to (PRO215) IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225 | IMMUNOGLOBULIN, FAB COMPLEX, IDIOTOPE, ANTI-IDIOTOPE
3spv:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A PEPTIDE-HLA COMPLEX | IMMUNOLOGY, RECEPTOR, HLA, HLA-B*0801, EBV, MHC, TCR, T CELL, IMMUNE SYSTEM
3g04:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY | TSH RECEPTOR, GPCR, THYROID, GRAVES' DISEASE, AUTOIMMUNITY, RECEPTOR- AUTOANTIBODY COMPLEX, IMMUNE SYSTEM
2ckb:H (ASP212) to (TRP274) STRUCTURE OF THE 2C/KB/DEV8 COMPLEX | T CELL ANTIGEN RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX
2ckb:I (ASP212) to (TRP274) STRUCTURE OF THE 2C/KB/DEV8 COMPLEX | T CELL ANTIGEN RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX
3t4y:A (ILE143) to (ASN209) S25-2- KDO MONOSACCHARIDE COMPLEX | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, IMMUNE SYSTEM
3gjf:D (ASP227) to (TRP274) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3gjf:L (VAL147) to (PRO211) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3gjf:M (PRO155) to (PRO219) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3gml:A (PRO217) to (TRP279) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, SECRETED, IMMUNE SYSTEM
3gmo:A (PRO217) to (TRP279) STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF | CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM
3tbt:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
3tbt:J (ASP212) to (ARG273) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX
2r4r:H (GLY162) to (PRO212) CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR | TRANSMEMBRANE HELIX, G-PROTEIN COUPLED RECEPTOR, GLYCOPROTEIN, LIPOPROTEIN, PALMITATE, PHOSPHORYLATION, RECEPTOR, TRANSDUCER, SIGNALING PROTEIN
3gsn:B (HIS154) to (GLY241) CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3gso:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
2ddq:H (GLY162) to (PRO212) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT | MONOCLONAL ANTIBODY, 4-HYDROXY-2-NONENAL, IMMUNOGLOBULIN, IMMUNE SYSTEM
3tie:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE VACCINIA DERIVED PEPTIDE A11R IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB | ANTIGEN PRESENTATION, PEPTIDE BINDING, IGG, MHC, IMMUNE SYSTEM
2dyp:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF LILRB2(LIR2/ILT4/CD85D) COMPLEXED WITH HLA-G | IMMUNOGLOBULIN-LIKE, IMMUNE SYSTEM
4jrx:A (ILE213) to (TRP274) CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX | TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM
1qr1:A (ILE213) to (TRP274) POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE | PEPTIDE-BINDING SUPERDOMAIN, IMMUNE SYSTEM
1qr1:D (GLU212) to (TRP274) POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE | PEPTIDE-BINDING SUPERDOMAIN, IMMUNE SYSTEM
3h7b:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE | TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3h7b:D (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE | TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3u0w:H (PRO149) to (PRO213) AD RELATED MURINE ANTIBODY FRAGMENT | IMMUNOGLOBULIN, ANTIBODY, AMYLOID BETA, ALZHEIMER, IMMUNE SYSTEM
3h9z:A (VAL370) to (THR434) CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS | IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3h9z:A (ASP473) to (VAL543) CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS | IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3h9z:D (VAL370) to (THR434) CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS | IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1ffo:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH SYNTHETIC PEPTIDE GP33 (C9M/K1A) | MAJOR HISTOCOMPATIBILITY COMPLEX, CRYSTALLOGRAPHY, PEPTIDE BINDING, T CELL RECEPTOR, IMMUNE SYSTEM/SIGNALING PROTEIN COMPLEX
1fg2:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB | IG FOLD, IMMUNE SYSTEM
1fg2:D (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB | IG FOLD, IMMUNE SYSTEM
1fg2:G (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB | IG FOLD, IMMUNE SYSTEM
1fg2:J (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB | IG FOLD, IMMUNE SYSTEM
2v2w:D (GLU212) to (TRP274) T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT | IMMUNOGLOBULIN DOMAIN, COMPLEX (ANTIGEN-PEPTIDE), TCR, HIV, MHC, AIDS, MHC I, HLA-A2, MEMBRANE, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM, COMPLEX (ANTIGEN/PEPTIDE), UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, POLYMORPHISM, GLYCOPROTEIN, TRANSMEMBRANE
1rk0:A (ASP212) to (TRP274) MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE | MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM
1fzo:A (ASP212) to (TRP274) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN | MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM
3upr:A (GLU212) to (TRP274) HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR | HLA-B*57:01, MHC, ANTIGEN PRESENTING CELL, T-CELL RECEPTOR, HUMAN LEUKOCYTE ANTIGEN, DRUG HYPERSENSITIVITY, ABACAVIR HYPERSENSITIVITY, REPERTOIRE-ALTERING SMALL MOLECULE, IMMUNE RESPONSE, IMMUNOGLOBULIN- LIKE BETA-SANDWICH, IMMUNE SYSTEM
3upr:C (GLU212) to (TRP274) HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR | HLA-B*57:01, MHC, ANTIGEN PRESENTING CELL, T-CELL RECEPTOR, HUMAN LEUKOCYTE ANTIGEN, DRUG HYPERSENSITIVITY, ABACAVIR HYPERSENSITIVITY, REPERTOIRE-ALTERING SMALL MOLECULE, IMMUNE RESPONSE, IMMUNOGLOBULIN- LIKE BETA-SANDWICH, IMMUNE SYSTEM
4ki1:A (ASP473) to (VAL543) PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23 | IMMUNOGLOBULIN FOLD, LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM
4ki1:B (ASP473) to (VAL543) PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23 | IMMUNOGLOBULIN FOLD, LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM
4ki1:C (ASP473) to (VAL543) PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23 | IMMUNOGLOBULIN FOLD, LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM
3utq:A (ASP227) to (TRP274) HUMAN HLA-A*0201-ALWGPDPAAA | MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, IMMUNE SYSTEM
1s7s:A (ASP212) to (TRP274) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS | LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM
3v5h:D (GLU212) to (TRP274) HLA-A2.1 KVAEIVHFL | PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM
2vr4:A (LYS722) to (ARG777) TRANSITION-STATE MIMICRY IN MANNOSIDE HYDROLYSIS: CHARACTERISATION OF TWENTY SIX INHIBITORS AND INSIGHT INTO BINDING FROM LINEAR FREE ENERGY RELATIONSHIPS AND 3-D STRUCTURE | LINEAR FREE ENERGY RELATIONSHIP, HYDROLASE, TRANSITION STATE MIMIC, MANNOSIDASE, GLYCOSIDE HYDROLASE
2vuo:A (PRO271) to (LYS338) CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT | IMMUNE SYSTEM, IMMUNOGLOBULIN C REGION, IGG, RABBIT, FC FRAGMENT, GLYCOSYLATION, IMMUNOGLOBULINS, IMMUNOGLOBULIN DOMAIN
2vuo:B (PRO271) to (LYS338) CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT | IMMUNE SYSTEM, IMMUNOGLOBULIN C REGION, IGG, RABBIT, FC FRAGMENT, GLYCOSYLATION, IMMUNOGLOBULINS, IMMUNOGLOBULIN DOMAIN
3ve0:A (GLY168) to (PRO218) CRYSTAL STRUCTURE OF SUDAN EBOLAVIRUS GLYCOPROTEIN (STRAIN BONIFACE) BOUND TO 16F6 | EBOLA, SUDAN, GLYCOPROTEIN, VIRUS SURFACE, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1t1y:A (ASP227) to (TRP274) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
4l29:A (GLU212) to (TRP274) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:C (GLU212) to (TRP274) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:I (GLU212) to (TRP274) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:K (GLU212) to (TRP274) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:Q (GLU212) to (TRP274) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:U (GLU212) to (TRP274) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:W (GLU212) to (TRP274) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l29:Y (GLU212) to (TRP274) STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM
4l3c:C (GLU212) to (TRP274) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:K (GLU212) to (TRP274) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:S (GLU212) to (TRP274) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:W (GLU212) to (TRP274) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4l3c:Y (GLU212) to (TRP274) STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT | MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION
4zpv:A (PRO149) to (PRO212) STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2) | VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2gt9:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE | MELAN-A/MART-1 PEPTIDE, DECAPEPTIDE, MHC CLASSI, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
2gt9:D (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE | MELAN-A/MART-1 PEPTIDE, DECAPEPTIDE, MHC CLASSI, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
2gtw:A (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION | MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A27L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
2gtw:D (GLU212) to (TRP274) HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION | MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A27L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM
2w59:B (GLY393) to (TYR447) STRUCTURE OF AN AVIAN IGY-FC 3-4 FRAGMENT | IMMUNOGLOBULIN, AVIAN, IGY FC, IMMUNE SYSTEM
1tjg:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE | 2F5; ANTIBODY; GP41; HIV-1; NEUTRALIZING; MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
2h2s:E (GLY170) to (PRO220) CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN- | CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT
1hi6:B (GLY161) to (PRO211) ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE | IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIBODY/PEPTIDE), POLYSPECIFICITY, CROSSREACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1
3iu3:H (GLY164) to (PRO215) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, BASILIXIMAB, SIMULECT, THERAPEUTIC ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, MEMBRANE, RECEPTOR, SUSHI, TRANSMEMBRANE, IMMUNE SYSTEM
1hsa:A (GLU212) to (TRP274) THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC | HISTOCOMPATIBILITY ANTIGEN
1hsa:D (GLU212) to (TRP274) THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC | HISTOCOMPATIBILITY ANTIGEN
2hjl:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE | B57, HLA, HIV, IMMUNE SYSTEM
1i1f:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y | HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM
2wqr:A (ASP473) to (VAL543) THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN
2wqr:B (ASP473) to (VAL543) THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC | IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN
4lvo:C (GLY169) to (PRO219) CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX WITH ADDED CACL2 | ALPHA BETA, ENZYME-PRODOMAIN COMPLEX, ROSSMANN FOLD, SERINE PROTEASE, CALCIUM IONS, PRODOMAIN, PARASITOPHOROUS VACUOLE, HYDROLASE- INHIBITOR-IMMUNE SYSTEM COMPLEX
3wfb:H (GLY173) to (PRO223) REDUCED CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT | METAL-BINDING, MEMBRANE PROTEIN, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX
1uxw:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS | IMMUNE SYSTEM-PEPTIDE COMPLEX, COMPLEX (ANTIGEN/PEPTIDE), IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2709
4mhj:K (PRO151) to (PRO227) CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1) | H5N1 INFLUENZA VIRUS, EPITOPE, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3wjj:C (LYS117) to (THR168) CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB | RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM
1vad:A (ASP212) to (TRP274) MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE | HISTOCOMPATIBILITY ANTIGEN, CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC I, PEPTIDE, COMPLEX (MHC I/PEPTIDE) COMPLEX
4mng:A (PRO215) to (TRP277) STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE | IMMUNGLOBULIN, HISTOCOMPATIBILITY ANTIGENS, CD1, IMMUNOLOGICAL, LYMPHOCYTES, GAMMA DELTA T CELL, T CELL RECOGNITION, SELF- RECOGNITION, MYELIN, INTESTINAL EPITHELIAL LYMPHOCYTES, HUMAN, LIPID BINDING, SELF-LIGAND,, GLYCOPROTEINS, CELL-SURFACE RECEPTORS, IMMUNE SYSTEM
4mng:C (PRO215) to (TRP277) STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE | IMMUNGLOBULIN, HISTOCOMPATIBILITY ANTIGENS, CD1, IMMUNOLOGICAL, LYMPHOCYTES, GAMMA DELTA T CELL, T CELL RECOGNITION, SELF- RECOGNITION, MYELIN, INTESTINAL EPITHELIAL LYMPHOCYTES, HUMAN, LIPID BINDING, SELF-LIGAND,, GLYCOPROTEINS, CELL-SURFACE RECEPTORS, IMMUNE SYSTEM
1vgk:A (ASP212) to (TRP274) THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, H-2KD AT 2.0 A RESOLUTION | MHC, H-2KD, CRYSTAL STRUCTURE, CLASS I, IMMUNE SYSTEM
2xfx:A (GLU212) to (TRP274) CATTLE MHC CLASS I N01301 PRESENTING AN 11MER FROM THEILERIA PARVA | IMMUNE SYSTEM, MAJOR HISTOCOMPATIBILITY, EAST COAST FEVER, THEILERIOSIS
3wuw:A (GLU212) to (TRP274) KIR3DL1 IN COMPLEX WITH HLA-B*57:01.I80T | IMMUNE RECEPTOR COMPLEX, PROTEIN BINDING
2jix:G (GLU143) to (ARG211) CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR | IMMUNE SYSTEM, RECEPTOR, TRANSMEMBRANE, RECEPTOR SOLUBLE DOMAIN, ANTIBODY, RECEPTOR-IMMUNE SYSTEM COMPLEX
5c0g:A (ASP227) to (TRP274) HLA-A02 CARRYING YLGGPDFPTI | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
4nny:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2 | NONPHOSPHORYLATED EPITOPE, PEPTIDE-MHC COMPLEX, MHC, POST TRANSLATIONAL MODIFICATION, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, TUMOR ANTIGEN, IMMUNE SYSTEM-ANTIGEN COMPLEX
1kpv:A (ASP212) to (TRP274) HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/SEV9 | MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE-MHC, IMMUNE SYSTEM
5c7x:M (PRO149) to (PRO213) CRYSTAL STRUCTURE OF MOR04357, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
3jts:A (GLU212) to (TRP274) GY9-MAMU-A*02-HB2M | ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3jts:D (GLU212) to (TRP274) GY9-MAMU-A*02-HB2M | ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1lek:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8 | MHC CLASS I ALLOGENEIC COMPLEX WITH PEPTIDE, IMMUNE SYSTEM
2zuq:F (PRO155) to (LYS215) CRYSTAL STRUCTURE OF DSBB-FAB COMPLEX | DISULFIDE BOND, MEMBRANE PROTEIN, FAB, E. COLI, CELL INNER MEMBRANE, CELL MEMBRANE, CHAPERONE, ELECTRON TRANSPORT, MEMBRANE, OXIDOREDUCTASE, REDOX-ACTIVE CENTER, TRANSMEMBRANE, TRANSPORT, OXIDOREDUCTASE/IMMUNE SYSTEM COMPLEX
1mhe:A (GLU212) to (TRP274) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E | HLA-E, HLA E, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HLA, BETA 2 MICROGLOBULIN, PEPTIDE, LEADER PEPTIDE, NON- CLASSICAL MHC, CLASS IB MHC
1mhe:C (GLU212) to (TRP274) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E | HLA-E, HLA E, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HLA, BETA 2 MICROGLOBULIN, PEPTIDE, LEADER PEPTIDE, NON- CLASSICAL MHC, CLASS IB MHC
1mlb:B (PRO152) to (PRO215) MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME | IMMUNOGLOBULIN, IMMUNE SYSTEM
3kpl:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN | HLA B*4402, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, IMMUNE SYSTEM
3kpp:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN | HLA B*4405, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM
1ydp:A (GLU212) to (TRP274) 1.9A CRYSTAL STRUCTURE OF HLA-G | IMMUNE SYSTEM
1ymh:B (GLY162) to (PRO212) ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W | ENGINEERING OF CRYSTAL CONTACTS, PPL-FAB COMPLEX, IMMUNE SYSTEM
3kxf:C (GLU212) to (TRP274) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER | MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3kxf:I (GLU212) to (TRP274) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER | MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
5def:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF B*27:04 COMPLEX BOUND TO THE PVIPR PEPTIDE | IMMUNE SYSTEM-COMPLEX, IMMUNE SYSTEM, MHC MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2704
5dfv:E (PRO1035) to (PRO1098) CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04 | HELICAL BUNDLE, CELL ADHESION, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
1n5a:A (ASP212) to (ARG273) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV | MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM
1n5a:G (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV | MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM
1n5a:J (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV | MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM
4prb:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-A4 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
4prd:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-D5 | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
3lex:H (PRO148) to (PRO211) 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41 | HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, VACCINE DESIGN
3lex:A (GLY161) to (PRO211) 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41 | HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, VACCINE DESIGN
3lkq:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1977 STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3lks:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN | HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
5dvn:A (PRO271) to (SER337) FC K392D/K409D HOMODIMER | HEAD-TO-TAIL HOMODIMER, IMMUNOGLOBULIN, FC, IGG1_FC - NONE, IMMUNE SYSTEM
1zs8:A (ASP211) to (TRP273) CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM
1zs8:C (ASP211) to (TRP273) CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM
1zs8:E (ASP211) to (TRP273) CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM
1zs8:G (ASP211) to (TRP273) CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM
1zs8:I (ASP211) to (TRP273) CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 | MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM
4qgt:A (ASP376) to (LEU443) THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON | IGG1, IMMUNOGLOBULIN-LIKE BETA-SANDWICH, IMMUNE SYSTEM
3mlv:N (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mlx:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3bh9:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF RTY PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, HLA-A2, ANCHOR RESIDUE, TUMOR ANTIGEN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNOGLOBULIN DOMAIN, PHOSPHOPROTEIN, IMMUNE SYSTEM
3bhb:A (ASP227) to (TRP274) CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, HLA-A2, ANCHOR RESIDUE, TUMOR ANTIGEN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNOGLOBULIN DOMAIN, PHOSPHOPROTEIN, IMMUNE SYSTEM
3mv8:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG | HLA B*3501, EBV, TCR, TCRPMHC COMPLEX, HPVG, TCR POLYMORPHISM, IMMUNE SYSTEM
3bwa:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8- MER PEPTIDE FROM THE PP65 PROTEIN | HLA B*3508, CRYSTAL STRUCTURE, HCMV, PP65, IMMUNOLOGY, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, TEGUMENT PROTEIN, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM
3ch1:A (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100 | MHC, H-2DB, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, MELANIN BIOSYNTHESIS, IMMUNE SYSTEM
5fyl:H (PRO147) to (LYS207) CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22 | VIRAL PROTEIN, HIV, ENVELOPE, GLYCAN, TRIMER
3dmm:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE CD8 ALPHA BETA/H-2DD COMPLEX | T CELL CO-RECEPTOR CD8AB MHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, ENVELOPE PROTEIN, ALTERNATIVE SPLICING, POLYMORPHISM, IMMUNE SYSTEM
3dx7:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B*4403 PRESENTING 10MER EBV ANTIGEN | MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM
3p4n:D (ASP212) to (ARG273) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-PV EPITOPE YTVKFPNM, AN 8-MER PEPTIDE FROM PV | H2-KB, PV, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM
5hys:J (ASP473) to (VAL543) STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB | IMMUNE SYSTEM
5hys:K (GLY368) to (THR434) STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB | IMMUNE SYSTEM
4e0r:D (ASP223) to (TRP270) STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 | MHC I COMPLEX, NARROW BINDING GROOVE, IMMUNE SYSTEM
5i74:B (SER187) to (PRO237) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE | MEMBRANE PROTEIN
5id0:D (PRO155) to (PRO219) CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5ind:C (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION | HLA, HIV, QW9_E5D, IMMUNE SYSTEM
3qul:D (ASP212) to (TRP274) CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S) | MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, T CELL RECEPTOR, CELL SURFACE
3quy:A (PRO217) to (TRP279) STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3quz:A (PRO217) to (TRP279) STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
5jsa:A (PRO151) to (PRO227) UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128 | HIV-1 TRIMER, UFO, SOSIP, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4g6f:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE | IMMUNOGLOBULIN, MPER, ANTIBODY, IMMUNE SYSTEM
4g8i:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA B2705-KK10-L6M | TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM